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ABSTRACT 
 
ANGELA Y. GWALTNEY: Use of Psychotropic Medication in Foster Care and Related 
Outcomes 
(Under the direction of Dean F. Duncan) 
 
Children who enter foster care have experienced some of the most severe cases of abuse, 
neglect, and/or dependency. Because of these adverse experiences, their prevalence of mental 
health disorders is predictably higher than in the general population. Children in foster care also 
have high rates of psychotropic medication use, which has become a national concern. The 
literature in this area has also found the occurrence of risky medication practices such as 
polypharmacy, concomitant pharmacy, and prescribing to very young children (i.e., under 4 
years of age). However, studies have yet to explore the social effects of medicating children in 
foster care such as stabilizing foster care placements or supporting reunification with families. 
The following three-paper dissertation not only examines how children in foster care are 
receiving psychotropic medication but also the effects, both positive and negative, that using 
psychotropic medications has on the child’s foster care outcomes. 
Paper I is a literature review to synthesize the existing research on the factors related to 
the prescription of psychotropic medications among youth in foster care. An explicit strategy is 
specified to conduct a thorough and replicable search including dates, terms, search engines and 
databases used, and inclusion/exclusion criteria. A sensitivity analysis was also used to assess 
risk of publication bias. The PRISMA guideline was followed to conduct the literature review 
and to report the prevalence rate of psychotropic medication use among foster children in the 
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United States as well as characteristics of foster children who use psychotropic medication. 
Articles published between 1990 and 2016 were included in the search. After a two-step 
inclusion/exclusion process, 39 articles were identified to have met the inclusion criteria. Results 
of the meta-analysis found that the overall prevalence rate of psychotropic medication use for 
children in foster care was 32.9%. The paper also found that males, older youth, children with 
internalizing/externalizing behavior problems, children living in rural areas, as well as children 
placed in out-of-home placements were more likely to receive psychotropic medication. The 
odds of receiving psychotropic medication also varied by abuse type.  
Paper II is a descriptive study of children in foster care in North Carolina who received 
psychotropic medication. Foster care and Medicaid data were linked to create the sample of 
foster children from the state of North Carolina who entered into care between March 2006 and 
June 2012 (N = 30,657). Univariate analysis was performed for frequency distributions and 
measures of central tendency and variation. Chi-square tests were used to test linear trends over 
the study period and generalized linear modeling (GLM) was used to assess association of 
individual and contextual factors and medication use. About one in five foster children (20.9%) 
received a psychotropic medication during their time in care. Males, Whites, older children, and 
those with a mental health diagnosis were more likely to receive psychotropic medication. Those 
placed in kinship care were less likely to receive psychotropic medication. Among those who 
were medicated, disruptive disorder was the most commonly diagnosed mental illness and its 
prevalence grew throughout the study period. Stimulants were the most prescribed medication 
and taken by 59.0% of those who received medication. 
Paper III examines the impact of psychotropic medication on children’s foster care 
experiences such as their placement stability, length of time in care, and permanency outcomes. 
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Using the same linked administrative dataset, inverse probability of treatment weighting was 
calculated and applied to mimic a randomized study. The Cox proportional hazards model., 
Poisson count regression, and multinomial logit regression and were used to examine the effects 
of medication use on length of time in care, placement stability, and permanency outcomes (i.e., 
reunification, guardianship, adoption, or others). Results revealed that children on medication 
stayed in care longer, less likely to experience placement disruption, and more likely to exit to 
adoption. 
As a whole, the three papers synthesize findings from previous literature on what has 
been established in the research regarding psychotropic medication use and foster care; offer a 
deeper understanding on what characteristics are associated with psychotropic medication use 
among children in foster care; and extend the scope of existing research to the effects of 
medication on more proximal outcomes such as placement stability, length of time in care, and 
permanency outcomes. Furthermore, the innovative statistical analysis used demonstrates a novel 
approach to conduct causal analysis on large, administrative datasets.  
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INTRODUCTION 
 
USE OF PSYCHOTROPIC MEDICATION IN FOSTER CARE AND RELATED OUTCOMES 
 
Children in the foster care system are often victims of maltreatment or have experienced 
a host of traumatic experiences that may lead to the development of emotional and behavioral 
issues. The acute and chronic stressors associated with child maltreatment alters the biological 
stress systems that adversely affects brain development (De Bellis, 2001). National survey data 
suggest that nearly half of children in the foster care system have clinically significant behavioral 
issues (Burns et al., 2004; Leslie, Hurlburt, Landsverk, Barth & Slymen, 2004). Many of these 
children are treated with mind-altering psychotropic medication to treat their emotional and 
behavioral needs. A report commissioned by the Government Accountability Office (GAO) 
found prescribing rates for this population ranging from 20% to 40%, which is 2.7 to 4.5 times 
the rate of prescribing for non-foster youth, even when controlling for socioeconomic status 
(2011). Increased national attention to the high rate of psychotropic medication use in foster care 
has exposed the need for research that helps better understand the intersection of child welfare 
and the medicalization of mental health care.  
There are several theories as to what is causing the high incidence of psychotropic 
medication use for children in foster care. For one, it may be the result of higher incidence of 
emotional and behavioral needs compared to non-foster children because of the experiences of 
abuse, neglect, or dependency that brought the children into state custody (Burns et al., 2004; 
English et al., 2005). Another explanation may be that the instability resulting from removal 
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from the home and being placed in a new environment (and oftentimes multiple placements) may 
be a traumatic experience in and of itself, and children may simply be reacting to these 
disturbances by responding in unhealthy ways (Rubin, O’Reilly, Luan, & Localio, 2007; Simms, 
1991). The strained mental health system (e.g., a shortage of well-trained mental health 
professionals specialized in treating children and adolescents; Burns et al., 2004) and 
reimbursement structure that incentivizes medication over therapy (Matone, Zlotnik, Noonan, 
Miller, & Rubin, 2015) may also contribute to the high use of pharmacological treatments as 
opposed to non-pharmacological alternatives. Alternatively, children who enter into state custody 
experience greater scrutiny under the supervision of social workers, foster parents, judges, and 
teachers who may be overzealously assessing age-appropriate child/adolescent behavior as 
deviant (Chubinsky & Hojman, 2013; Conrad & Slodden, 2013). 
Regardless of why children are medicated, there are strong criticisms of the ubiquity of 
medication therapy among children in foster care. The negative side effects of psychotropic use 
from clinical studies with adult samples are already well known (National Institute of Mental 
Health [NIMH], 2009), and children are even more sensitive to medication side effects (Correll 
et al., 2009; Vitiello et al., 2009). That is, the developmental changes experienced by children 
may affect the safety and efficacy of medications. And yet, most medication studies are not 
conducted with children due to ethical reasons (Spetie & Arnold, 2007). Some critics argue that 
pharmacological treatments are not the best form of treatment and that instead, 
psychotherapeutic forms of treatment are necessary to address the underlying issue of trauma 
(Kapur, 2003). Along those lines, the high rates of medication use may be an indication of the 
overreliance on psychotropic medications in the mental health system, at the expense of other 
more costly and time-consuming therapies that are effective and carry less risk of adverse side 
3 
effects (Bellamy, Gopalan, & Traube, 2010; Compton et al., 2004; Correll, 2010; Olfson, 
Crystal, Huang, & Gerhard, 2010; Landsverk, Burns, Stambaugh, & Reutz, 2009). Some even 
argue that children are being medicated to appease overburdened parents and teachers rather than 
what is in the best interest of the child (Miller, 2009) 
Despite strong criticism of the use of psychopharmacological treatments, physicians use 
their clinical experience and expertise to determine the best course of action for their patients. 
However, if they are to make an informed treatment and prescribing decision, more data on the 
effects of psychotropic medication are needed. Current clinical evidence for psychotropic 
medication treatment of adolescent psychiatric disorders varies widely across medication class 
and disorder. Although stimulants are a well-established treatment for adolescent attention-
deficit/hyperactivity disorder (ADHD) (Kaplan & Newcorn, 2011), clinical trials provide only 
modest support for the short-term efficacy antidepressants for major depressive disorders and for 
several anxiety disorders in adolescents (Bridge et al., 2007). The use of antipsychotic 
medication for adolescents only have limited empirical support for schizophrenia, bipolar I 
mania, mixed mania, and autism and there are currently no well-established psychiatric 
indications of anxiolytics or mood stabilizers for adolescents (Vitiello et al., 2009).  
To our knowledge, there are no studies on the effects of psychotropic medication on 
foster care experiences and outcomes. This dissertation addresses the need for more information 
on how psychotropic medication impacts foster children’s experiences in care and leaving care 
by providing new data on the effects of psychotropic medication on foster care outcomes so that 
administrators and other helping professionals can make a more informed analysis of the risks 
and benefits associated with prescribing psychotropic medication. Specifically, this dissertation 
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examines the effects of medication on the foster care experience, including children’s placement 
stability, length of time in care, and permanency outcomes.  
Paper I, “The Use of Psychotropic Medication for Children in Foster Care: A Systematic 
Review and Meta-Analysis,” is a systematic literature review to determine the state of 
knowledge on contributing factors for prescribing psychotropic medication. Methods outlined by 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA; 
Moher, Liberati, Tetzlaff, & Altman, 2009) were used to amass relevant articles in the area of 
psychotropic medication use among foster children in the United States from 1990 to 2016. After 
a two-step inclusion/exclusion process, data from the sample of articles were extracted for a 
meta-analysis. Paper I presents what has been established in the body of research to date 
regarding the incidence of psychotropic medication use among children in foster care as well as 
characteristics of children in foster care who are prescribed psychotropic medication. The results 
of Paper 1 establish findings from the aggregate body of work, identify gaps in the literature for 
future studies, and critically examine how this area of research can be improved. 
Paper II, “Psychotropic Medication Use Among Children in the Foster Care System,” 
examines the prevalence of psychotropic medication use and the characteristics associated with 
the use of psychotropic medication for one state using a linked, administrative dataset. This 
paper addresses one of the gaps in the literature identified in Paper I: the need for more 
quantitative and longitudinal research from varied data sources. Data was linked from two 
administrative datasets, foster care data and Medicaid data, to observe 30,657 children who 
entered foster care between March 1, 2006, and June 30, 2012. Information on medical treatment 
and mental health treatment was extracted from Medicaid fee-for service reimbursement claims 
for services rendered. Descriptive analysis was conducted to understand what characteristics may 
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influence psychotropic medication treatment. The results of Paper II was used to inform 
statistical controls needed in research in the area of psychotropic medication use and children in 
foster care. Further, the results identifies potential subpopulations that may be particularly 
vulnerable to possible over-medication. 
Paper III, “Effects of Medication on Foster Care Outcomes,” analyzes the effects of 
medication on placement stability, length of time in care, and permanency outcomes. Because 
medication use is not a random occurrence, propensity score analysis (PSA) was conducted to 
mimic randomization of treatment and control group (i.e., medicated foster youth vs. non-
medicated). PSA balanced the characteristics of the youth who used psychotropic medication and 
those who did not in order to address bias from confounding factors, which allowed for causal 
analysis to be performed (Rosenbaum & Rubin, 1983). In particular, the inverse probability of 
treatment weighting (IPTW) was used to adjust for the differential probability of selection of 
foster children in the medication treatment and non-medication treatment groups. Paper III helps 
enhance foster care planning to become more holistic by considering the effects of medication on 
foster care experiences and outcomes. 
As a whole, the three papers that constitute the dissertation establish new knowledge by 
synthesizing relevant findings in the literature, and then expanding on those findings by 
analyzing psychotropic medication use among a large sample of foster children longitudinally. 
Moreover, the papers fill a significant gap in the literature by expanding the scope of the research 
on psychotropic medication use beyond descriptive analysis, allowing us to conduct causal effect 
analysis and begin to understand the effects of medication on foster care experiences and 
outcomes. 
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PAPER I 
 
THE USE OF PSYCHOTROPIC MEDICATION FOR CHILDREN IN FOSTER CARE: A 
SYSTEMATIC REVIEW AND META-ANALYSIS 
 
Abstract 
Ever since the high usage rates of psychotropic medication among children in foster care 
has been brought to the nation’s attention, there has been a growing body of research in an effort 
to better understand this topic (Birnbaum et al., 2013; Barnett et al., 2016; Leslie, Raghavan, 
Zhang, & Aarons, 2010; Mackie et al., 2011; Zito et al., 2008; Zito et al., 2013). However, a 
systematic review has yet to be conducted that broadly examines the findings of these studies. 
The purpose of this work is to review the relevant literature related to the use of psychotropic 
medication for children in foster care, including prevalence rates and predictors of psychotropic 
medication use. This paper helps understand what the research has established in this area and 
deficits in the literature that can be explored in future work. 
Keywords: Foster care; Psychotropic medication; Systematic review, Meta-analysis 
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Introduction 
An estimated 400,540 children are in foster care across the United States (Child Welfare 
Information Gateway, 2013; NIMH, 2009). These children have experienced some of the most 
adverse and stressful challenges, such as being victim to abuse or neglect or witnessing extreme 
violence and trauma, that lead to profound mental health issues and require some form of 
psychological treatment (Stambaugh et al., 2013; U.S. Department of Health and Human 
Services [DHHS], 2007). Common secondary and associated responses to childhood trauma 
include depression, aggression, substance abuse, physical illnesses, low self-esteem, identity 
confusion, difficulties in interpersonal relationships, and guilt and shame (Carlson & Dalenberg, 
2000). The stress of experiencing abuse makes the children in the child welfare system more 
vulnerable to mental problems such as post-traumatic stress disorder (PTSD), conduct disorder, 
and learning, attention, and memory difficulties (Dallam, 2001; Perry, 2001).  
Among treatment options, the prescribing of psychotropic medication among all children 
and adolescents has grown in the past two decades, but the rate has been far greater in the foster 
care population, even after controlling for similar socioeconomic backgrounds (Harrison, 
Cluxton-Keller, & Gross, 2012). Estimates of the percentage of foster care youth who receive 
psychotropic medication range from 13% to 25% (Gardner & Soeken, 2005; Leslie et al., 2010; 
Zito, Safer, Zuckerman, Zito et al., 2008) which are far higher than the general population.  
The psychotropic medications prescribed are not approved for children and are being 
used off-label to treat diagnoses such as ADHD (Attention Deficit/Hyperactivity Disorder), 
conduct disorder, depression, anxiety and developmental delay. The practice of 
psychopharmacological treatment has grown in popularity despite serious side effects associated 
with the use of psychotropic medications in children (e.g., weight gain, type 2 diabetes, 
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cardiovascular disease) and lack of evidence of efficacy for the treatment of many of the mental 
and behavioral health disorders it is being used to treat. Metabolic abnormalities caused by 
psychotropic medication use in youth can have both short- and long-term health implications. 
Because childhood is a period of rapid physiological and neurological changes, children react 
differently to psychotherapeutic medication which may explain their greater sensitivity to the 
negative side effects compared to fully developed adults.  
The revelation of high rates of psychotropic medications in the foster care system has 
raised alarm among government officials, physicians, and other advocates (GAO, 2011; Szilagyi, 
Rosen, Rubn, & Zlotnik, 2015). Some of the questionable practices prevalent in foster care are 
off-label medication use, polypharmacy (i.e., the administration of two or more psychotropic 
medication), and prescribing to very young youth (i.e., under the age of 4 years) (Medicaid 
Medical Directors Learning Network, 2010; Naylor et al., 2007; Zito et al., 2008b).  
Ever since the growing practice of prescribing children in foster care psychotropic 
medication has been brought to the attention of the child welfare field, several research studies 
have been conducted and published. However, as of yet, a systematic literature review 
synthesizing the existing research on prevalence rates and the factors related to the prescription 
of psychotropic medications among youth in foster care has not been conducted. This paper fills 
that void and provides a strong foundation in better understanding how mental health needs of 
children in the United States’ foster care systems are being met and the characteristics associated 
with medication use. 
Method 
A systematic review was conducted to collect research studies that meet the eligibility 
criteria and addresses the research questions (1) What is the rate of psychotropic medication use 
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among children in the U.S. foster care system and (2) What characteristics are associated with 
the prescription of psychotropic medication among children who are in foster care? The key 
characteristics of the systematic review are framed in the PICOS research question format, a 
model used to frame and define a research question. The PICOS elements include 
problem/patient/population, intervention/indictor, comparison, outcome, and study type (Table 
1). Once a sample of papers was identified, a meta-analysis was conducted. A meta-analysis is a 
subset of systematic review that assesses and consolidates a body of research (Haidich, 2010). 
Table 1. PICOS research question 
Acronym Definition Description 
P Patient or problem Children in the U.S. foster care system 
who are prescribed psychotropic 
medication 
I Intervention Psychotropic medication 
C Control or comparison Children in the U.S. foster care system 
who are not prescribed psychotropic 
medication 
O Outcome Use of psychotropic medication 
S Study type Quantitative 
 
Literature Search and Study Selection 
A literature search was conducted using the electronic databases PsychINFO, PubMED, 
EMBASE, Cochrane, ERIC, CINAHL, ProQuest’s Dissertations and Theses Global, Social 
Services Abstracts, and Social Work Abstracts. Search terms in various combinations were used 
including (foster*, kin*, relative*, “child welfare,” “out-of-home”) AND (psychotrop*, 
antidepress*, antipsychotic*, mood stabilizer, benzo*, anticonvul*). The asterisks served to 
produce all iterations of the search term. These search terms were chosen because they are the 
most commonly used terms in the United States to describe the population and medications of 
interest. If the electronic databases allowed, resulting articles were filtered by “English 
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language” and publication date. Duplicate articles were discarded. The final search (described 
below) was performed on February 6, 2017. 
Inclusion and exclusion criteria. Peer-reviewed journal articles published between 1990 
and 2016 fulfilling the following characteristic were included: peer reviewed, quantitative studies 
involving children in child welfare and the use of psychotropic medication. The published date 
criterion was chosen because psychotropic medication use in foster children was not an area 
studied prior to 1990. Exclusion criteria were as follows: articles in languages other than English, 
articles without primary quantitative data (e.g., letters to the editor, book reviews), and grey 
literature (e.g., conference proceedings). Grey literature was excluded because the peer-review 
process is generally less rigorous and often does not include enough detail to perform a meta-
analysis. 
Study selection. Study selection was conducted and reported in accordance with the 
Preferred Reporting Items of Systematic reviews and Meta-Analyses (PRISMA) guidelines 
which were developed by an international group of researchers to increase the reporting quality 
of systematic reviews (Moher, Liberati, Tetzlaff, Altman, & The PRISMA Group, 2009). 
PRISMA is an evidence-based guideline that provides a minimum set of items for reporting in 
systematic reviews and meta-analyses. A PRISMA recommended flowchart depicting the flow of 
information through distinct phases of a systematic review to illustrate the identification, 
screening, eligibility assessment, and inclusion of articles was also provided. 
A two-step inclusion/exclusion process was used to eliminate unrelated articles and 
create the final literature sample. Records that could be excluded at the title and abstract level 
were discarded. Second, the whole article was checked to determine whether the research was 
relevant to the study question by searching for prevalence rates, reference to outcome results of 
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child welfare-involved youth, and propensity to receive psychotropic medication. Studies that 
did not address the research question of the prevalence of psychotropic medication use among 
U.S. foster children and characteristics related to the use of psychotropic medication were 
excluded. Articles that were not available online were requested through the library service at the 
University of North Carolina at Chapel Hill.  
Study Endpoints and Measured Outcomes 
The endpoints of interest were the incidence of psychotropic medication use in foster 
children or child welfare-involved youth. Predictors of psychotropic use including age, race, and 
geography were also extracted from the literature. 
Data Extraction 
Meta-analysis was conducted using the data collected from the systematic literature 
review search. Meta-analysis is a statistical procedure used to combine data from across studies 
and identify a common treatment effect (or effect size). The aim is to derive a pooled estimate 
that is closest to the population estimate. Data from full-text articles were extracted by one 
author (A.G.). For each article, prevalence rates, prescription likelihood, and other relevant data 
were entered into a database (Excel 2016).  
The odds ratio (OR) is the most common measure of effect in dichotomous data. If an OR 
was unavailable, the effect size was calculated from other statistics (e.g., regression coefficient 
β). The OR [with 95% confidence interval (CI)] was used as the effect size index. Each OR was 
transformed into a Fisher’s Z coefficient, averaging across coefficients, and converting back to 
an OR. The correlation was converted to an effect size (Fisher’s Z) using the standard formula:  
𝐹𝑖𝑠ℎ𝑒𝑟𝑍 = .05 ∗ 𝐿𝑜𝑔 (
1 + 𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛
1 − 𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛
) 
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𝑆𝐸𝐹𝑖𝑠ℎ𝑒𝑟𝑍 =
1
√𝑁 − 3
 
The transformation from Fisher’s Z to correlation is given by 
𝐶 = 𝐸𝑥𝑝(2 ∗ 𝐹𝑖𝑠ℎ𝑒𝑟𝑍) 
𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 =  (
𝐶 − 1
𝐶 + 1
) 
𝑆𝐸𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 = (1 − 𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛
2) ∗ 𝑆𝐸𝐹𝑖𝑠ℎ𝑒𝑟𝑍 
When multiple follow-up periods were studied, the most recent data were extracted and used for 
analysis to prevent over-counting similar study populations.  
Data Analysis 
Meta-analysis (Glass, 1976) is the statistical technique used to combine the results of a 
series of studies that address a common question. Results of the various studies are typically 
transformed to the same metric and represented as effect sizes for analysis. For this study, 
random effects meta-analyses were conducted to provide a weighted means estimate of incidence 
rates and the correlation between each variable and the use of psychotropic medication for 
children in foster care. The random-effects model was chosen because it has an underlying 
assumption that a distribution of effects exists and therefore, heterogeneity among study results 
(τ2) exists. When a study provided effect sizes for a linear random effects model, the beta was 
converted to the correlation statistic Cohen’s d by dividing the mean difference (𝛽) by the 
standard deviation of the residuals (𝜎). When the standard deviation was not available, it was 
estimated using the standard error and the sample size as follows: 
𝜎 = √𝑛 ∗ 𝑆𝐸 
𝑑 = 𝛽/𝜎 
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Such analyses were conducted where data were available from at least three studies. For 
each analysis, the I2 statistic was produced to index the total variation in correlation magnitude 
across studies due to between-study heterogeneity versus within-study heterogeneity (i.e., 
sampling error; Rosenthal, 1991). Overlapping bands of I2 values were used to categorize 
heterogeneity which is the degree of inconsistency in the study results. Values ranging between 
0% to 40% indicated minimal heterogeneity; 30% to 60%, moderate heterogeneity; 50% to 90%, 
substantial heterogeneity; and 75% to 100%, heterogeneity (Deeks, Higgins, & Altman, 2011). A 
p < 0.05 is considered statistically significant. Forest plots were produced to examine the 
distribution of effects across individual studies. All statistical analyses were performed using 
Comprehensive Meta-Analysis (version 3.3). 
Subgroup analysis.  There were five subgroup studies found in the systematic literature 
review: children with ADHD, antipsychotic medication users, older youth, expenditure outcome 
studies, and preschool-aged children (see Table 1). However, none of these subgroups had k ≥ 10 
studies available for analysis and therefore, meta-analysis was not undertaken for any subgroups. 
Sensitivity analysis. Analyses were re-conducted while limiting the data to studies 
classified as having low risk of bias to determine the effect of including studies classified as 
having high risk of bias. 
Assessment of publication bias. Publication bias is a concern with meta-analysis 
because it may lead to conclusions that are not a true representation of the population. 
Statistically significant results are more likely than non-significant results to be published 
(Rothstein, Sutton, & Borenstein, 2005). To assess possible publication bias, funnel plots were 
produced when the number of studies include in the analysis exceeded 10 (Sterne et al., 2011). 
The Funnel plot is a scatterplot with the study precision (e.g., standard error or study size) on the 
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vertical axis as a function of effect size on the horizontal axis. Large studies appear at the top of 
the graph and tend to cluster near the mean effect size. Smaller studies appear toward the bottom 
of the graph and are typically dispersed across a range of values because smaller studies tend to 
have greater sampling variation in effect size estimates. In the absence of a publication bias, 
studies are expected to be distributed symmetrically about the combined effect size. On the 
contrary, in the presence of bias, there is likely to be a higher concentration of studies on one 
side of the mean than the other. This reflects the fact that smaller studies (found at the bottom) 
are more likely to be published if they have larger than average effects which makes them more 
likely to meet the criterion for statistical significance.  
Two additional statistical tests were performed to assess the funnel plot. First, the Egger’s 
test of the intercept was conducted to test for asymmetry of the funnel plot (Egger et al., 1997). It 
assesses bias by using the inverse of the standard error to predict the standardized effect (i.e., 
effect size divided by the standard error). Second, the Begg Mazumbdar Rank Correlation Test 
was conducted to test the interdependence of variance and effect size (Begg & Mazumdar, 1997). 
Since large studies tend to be included in the analysis regardless of their treatment effect—
whereas small studies are more likely to be included only when they show a relative large 
treatment effect—Begg and Mazumdar suggested that this correlation can be used as a test for 
publication bias. The rank order correlation (Kendall’s τΒ) between the treatment effect and the 
standard error (driven primarily by sample size) is computed; a significant correlation may 
indicate the presence of bias. The Begg and Mazumdar test requires fewer assumptions than the 
Egger test but is insensitive to many types of bias to which the Egger test is sensitive (Sterne, 
Gavaghan, & Egger, 2000).  
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A “classic fail-safe N” test was also conducted as a test to determine whether the entire 
observed effect could be an artifact of bias (Rosenthal, 1979). This test provides the number of 
null effect studies needed to raise the p value associated with the average effect above an 
arbitrary alpha level (set at α = .05). According to researchers, results from meta-analysis can be 
interpreted as valid and thus resistant to bias due to researchers’ tendencies to exclude 
nonsignificant findings when the fail-safe N reaches the 5k + 10 limit (Carson, Schriesheim, & 
Kinicki, 1990; Rosenthal, 1979).  
Quality and Risk of Bias in Individual Studies 
The quality of each article was appraised using the Effective Public Health Practice 
Project (EPHPP) Quality Assessment Tool for Quantitative Studies (EPHPP, 2008; Jackson & 
Waters, 2005) recommended by the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins & Green, 2006). With EPHPP, the quality of each study is rated on eight 
methodological qualities: selection bias, design, confounders, blinding, data collection methods, 
withdrawals and dropouts, intervention integrity, and analysis (see Appendix A). Based on these 
qualities, each study is given a score out of 3 with 1 being the strongest, and 3 the weakest. The 
psychometric properties of EPHPP have been validated for inter-rater reliability and concurrent 
validity (Armijo-Olivo, Stiles, Hagen, Biondo, & Cummings, 2010; Thomas, Ciliska, Dobbins, 
& Micucci, 2004). Low-rated studies were not excluded because the use of psychotropic 
medication among children in foster care is a specialized subpopulation that has a relatively 
small sample of studies conducted in this area. The purpose of the quality assessment was to 
provide full transparency to the readers on the overall quality of the studies included in the meta-
analysis. 
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Results 
Search Results 
Results of the literature review were documented using the Preferred Reporting Items of 
Systematic reviews and Meta-Analyses (PRISMA). Figure 1 summarizes the results of the 
systematic search. The database search returned 350 entries. Deleting duplicate articles left 326 
potential articles for assessment. Following evaluation of titles and abstracts, 124 articles failed 
to meet inclusion criteria and were excluded. A total of 202 articles were subsequently selected 
for full-text review; 162 articles were excluded after full-text review.  
 
Figure 1. PRISMA flow chart 
Common reasons for exclusion included grey literature (e.g., conference abstracts, book 
reviews), wrong patient population, and wrong study design (i.e., not quantitative). A total of 40 
studies met the inclusion criteria. Not all studies contributed relevant information for every 
analysis performed. For example, five subgroups or unique outcome analyses were identified but 
were not included in the analysis due to their narrow population group. 
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Study Characteristics 
A summary of studies is provided in Table 2. Children included were either in the foster 
care system or had been investigated for abuse or neglect. Most were retrospective cross-
sectional studies. Medicaid claims were a common data source. Studies were conducted between 
the mid-1990s and 2013. Most had EPHPP ratings of 2 out of 3 indicating a moderate assessment 
of quality in the included studies with a mean score of 1.77 (SD = 0.58). The mean rating for 
each of the components were moderate as well. 
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Quantitative Synthesis 
Psychotropic medication use rates in foster care. Out of the 40-study sample, twenty 
(20) studies reported rates of psychotropic medication use for children in foster care (see Table 
3). Because of the high degree of heterogeneity, the random effects model was used. Based on 
the meta-analysis of the reporting of 20 studies, the overall prevalence rate of psychotropic 
medication use for children in foster care is 32.9% (95% CI = .29–.37). The lowest reported rate 
was 10.3% (Zima et al., 1999b) and the highest was 82.0% (Baker et al., 2007b). There was high 
degree of heterogeneity (I2 = 99.6%, τ2 = 0.160, p <.001). The wide range of medication use is 
indicative of the diverse study population (even within foster care research) and study 
methodologies used in studies involving children in foster care and their use of psychotropic 
medication. For example, some studies focused only on children in residential treatment care 
settings.   
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Correlates of psychotropic medication use. Results of the meta-analyses for the 
correlates of psychotropic medication use for children in foster care are presented in Table 4. 
There was no list of correlates a priori and the correlates were extracted from the systematic 
literature review. Correlates studied in at least three articles were included for analysis. Because 
of the small number of studies, meta-analyses could not be conducted for emotional abuse, 
continuous variable of age, ages in which reference groups were not 3-5 years old, caregiver 
education, caregiver employment, clinician diagnosis of impairment, county pediatrician ratio, 
county psychiatrist ratio, county poverty level, agency climate, certain insurance types, group 
home placement, placement instability, time in placement, individual states, and state/county 
administration type.  
Table 4. Meta-analytic results for associations between psychotropic medication use and 
demographic variables 
   95% CI   
Associations k OR Lower Upper p-value I2 
Foster Care 4 1.61 1.05 2.49 0.03 97.44% 
       
Abuse       
     Physical (ref. No physical abuse) 4 1.41 1.21 1.64 0.00 0.00% 
     Sexual (ref. No sexual abuse) 4 1.21 0.99 1.47 0.06 0.00% 
     Abandonment (ref. No abandonment) 4 1.29 0.99 1.68 0.06 0.00% 
     Neglect (ref. No neglect) 4 0.82 0.69 0.96 0.02 0.00% 
Male (ref. female) 6 2.20 1.90 2.54 0.00 9.91% 
Age       
     6-11 (ref. 3-5) 3 6.04 4.69 7.77 0.00 0.00% 
     12-13 (ref. 3-5) 3 6.56 4.94 8.70 0.00 0.00% 
     ≥14 (ref. 3-5) 3 6.72 5.09 8.86 0.00 0.00% 
Race       
     Black (ref. White) 6 0.64 0.56 0.75 0.00 0.00% 
     Hispanic (ref. White) 5 0.89 0.71 1.12 0.32 0.00% 
     Other/Mixed race/ethnicity (ref. White) 6 1.18 0.79 1.76 0.41 31.18% 
Out-of-home placement (ref. In-home placement) 5 2.00 1.73 2.31 0.00 0.00% 
Child Behavior Checklist (CBCL)       
    Externalizing score ≥64 5 4.29 3.74 4.91 0.00 0.00% 
    Internalizing score ≥64 4 1.43 1.23 1.65 0.00 3.46% 
Fair or poor health (ref. Excellent or good health) 3 1.88 1.45 2.45 0.00 0.00% 
Rural (ref. Urban) 3 1.05 0.81 1.37 0.70 0.00% 
Primary care case management (PCCM) insurance 
only (ref. Fee-for-service [FFS] only) 
3 0.63 0.52 0.77 0.00 0.00% 
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Foster care. Analysis of k = 4 studies revealed that children in foster care are 61% more 
likely to receive psychotropic medication than their non-foster care counterparts. This mean 
effect was statistically significant. There were high levels of true heterogeneity across studies (I2 
= 97.44%), with study-specific estimates ranging from OR = 1.05 to OR = 2.49.  
Abuse. Children in foster care who were physically abused (k = 4 studies) are 41% more 
likely to receive psychotropic medication than children with no history of physical abuse, 
whereas children in foster care who were neglected (k = 4 studies) are 18% less likely to receive 
psychotropic medication than children with no history of neglect. Neither showed evidence of 
true heterogeneity across studies (I 2 = 0.00%). The I 2 of 0.00% may be misleading because of 
the small sample size (von Hippel, 2015). This bias may be exacerbated by the fact that there 
were multiple studies from the same author. The mean effects of sexual abuse and abandonment 
were not statistically significant at p < .05. 
Gender. Data from k = 6 studies revealed that males in foster care had more than double 
the odds of receiving psychotropic medication than females (OR = 2.22). This mean effect was 
statistically significant and there were low levels of true heterogeneity across studies (I2 = 
14.56%). Study-specific estimates ranged from OR = 1.90 to OR = 2.54. 
Age. Age was significantly correlated with psychotropic medication user; those who were 
at least 6 years of age had six times the odds of receiving medication than those ages 3 to 5 
years. There was no evidence of true heterogeneity across studies (I2 = 0.00%). 
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Race. Black foster children had significantly lower odds of receiving psychotropic 
medication than their White counterparts (OR = 0.64, 95% CI = [0.56, 0.75]). Being of Hispanic 
ethnicity and being of Other/mixed race/ethnicity did not have a statistically significant 
correlation with psychotropic medication use. All these statistics had low levels of true 
heterogeneity across studies. 
Out-of-home placement. Foster children living in out-of-home placements (k = 5 studies) 
were twice as likely to receive psychotropic medication than those in in-home placements (OR = 
2.00, 95% CI = [1.73, 2.31]). This mean effect was statistically significant (p < .01). There was 
no evidence of true heterogeneity across studies (I2 = 0.00%). 
Behavior. Several studies have utilized the Child Behavior Checklist (CBCL) scores as a 
measure of a child’s behavioral problems (Achenbach & Rescorla, 2000; Achenbach & Rescorla, 
2001). Children with clinical scores ≥64 on the CBCL externalizing assessment had over twice 
times the odds of receiving psychotropic medication (k = 5 studies; OR = 2.00, 95% CI = [3.74, 
4.91]). Children with scores ≥64 on the CBCL internalizing assessment were 43% more likely to 
receive psychotropic medication (k = 4 studies; OR = 1.43, 95% CI = [1.23, 1.65]). Both mean 
effects were statistically significant and had no evidence of true heterogeneity across studies (I2 = 
0.00%).  
Health condition. Analysis of k = 3 studies revealed that foster children in Fair or Poor 
health were 88% more likely to receive psychotropic medication than children in Excellent or 
Good health (OR = 1.88, 95% CI = [1.45, 2.45]). Health status was captured by questions used 
by the Health Interview Survey since 1982 and provided by child’s caregiver report (Adams et 
al., 1999). This mean effect was statistically significant and there was no evidence of true 
heterogeneity across studies (I2 = 0.00%). 
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Rural setting. A few studies (k = 3) have included rural setting as a variable in their 
analysis. There was a weak positive association between rural geography compared to urban 
geography, although this mean effect was not statistically significant. There were no evidence of 
true heterogeneity across studies (I2 = 0.00%). 
Insurance type. Although there were several studies analyzing the relationship of 
insurance type to psychotropic medication use, there were few consistent measures of insurance 
coverage and type across studies. There was, however, sufficient data (k = 3 studies) to find a 
negative association between primary care case management (PCCM) insurance only compared 
to fee-for-service (FFS) insurance types (OR = 0.63). This mean effect was statistically 
significant (95% CI = .52–.77). There was no evidence of true heterogeneity across studies (I2 = 
0.00%). 
Sensitivity analysis. Sensitivity analysis was conducted by removing studies that were 
classified as having high risk of bias from the meta-analysis. Removing studies with a high risk 
of bias did not significantly alter results. Therefore, conclusions were generally robust to risk of 
bias. 
Publication bias. Funnel plots were produced to screen for potential publication bias for 
analyses where there were at least k = 10 studies. This criterion resulted in producing the funnel 
plot only of the overall meta-analysis for medication rates (see Figure 2). The results from 
assessing publication bias show conflicting conclusions. Visual examination of the funnel plot 
show that larger studies represented by plots towards the top of the inverted V tend to reside 
closer to the mean effect size while the “medium” and “smaller” studies seem to skew towards a 
more positive effect size. This plot may indicate a presence of publication bias in that smaller 
studies with reports of higher rates of psychotropic medication use in foster children may be 
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more likely to be published. The narrowness of the inverted V is quite narrow is indicative of a 
very large range of sample sizes represented in the studies used in this analysis. The average 
sample size in the analysis of the prevalence rate of foster youth medication use was 760,587 
with a standard deviation of 152,722.2.  
 
Figure 2. Begg’s funnel plot with pseudo 95% confidence limits 
 
Other methods of assessing publication bias appear to minimize the concern of the 
possible presence of publication bias. There appears to be an equal number of studies distributed 
on each side of the mean effect size which can be an indication that sampling error is random 
(although studies with positive effect sizes deviate further from the mean than studies with 
negative effect sizes). The Egger’s regression test for funnel plot asymmetry was not statistically 
significant for the correlation data (τ = 3.77, p = .17). The Begg Mazumdar rank correlation test 
supported this finding with a non-significant correlation of the Kendall’s tau b (τΒ = 0.12, p = 
.46) providing further support that there is no publication bias present. The Classic fail-safe N 
test revealed that 8,475 additional “null” studies would need to be located and included to 
invalidate the overall effect found in this meta-analysis. This value far exceeds the recommended 
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5k + 10 limit. It is to be noted that publication bias cannot be ruled out completely because of the 
low sensitivity (i.e., <20 studies; Sterne, Egger, & Smith, 2001).  
Discussion 
 This paper is the first systematic review and meta-analysis to evaluate the prevalence and 
predictors of psychotropic medication use for children in foster care. One must note that a wide 
range in prevalence rates was found in the literature which may be due to the lack of specificity 
or diverse focus even within the foster care population. Although there is a wide range in 
reported prevalence of psychotropic medication use for children in foster care, the meta-analysis 
that was conducted in this paper found that nearly a third of the children in foster care received 
psychotropic medication (32.9% across studies) which continues to the raise the concern that 
children in foster care are using psychotropic medication at very high rates. 
Because studies involving the use of psychotropic medication for children in foster care 
did not use a standardized variable list, a meta-analysis of all variables studied was not 
attainable. However, of the 18 separate predictor variables were able to be analyzed, 13 had a 
significant effect size. The meta-analysis found that children with a history of physical abuse, 
males, older children, children living in out-of-home placements, children with behavioral 
problems, and children with fair or poor health were more likely to receive psychotropic 
medication. Children with a history of neglect, Black children, and children in primary care case 
management Medicaid insurance systems were less likely to receive psychotropic medication.  
Another notable finding was that only one study identified examined causal effects of 
medication use on foster care experiences (Tai, Shaw, & DosReis, 2016). However, this study 
was limited to children receiving antipsychotic medication and not psychotropic medication in 
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general. The lack of studies of causal effects highlights an area of research that is understudied, 
and the field would benefit from greater examination by researchers. 
Policy Relevance  
Children in foster care were statistically more likely to receive psychotropic medication 
than non-foster children. As a vulnerable population, these children warrant additional attention 
around the decision-making process regarding medication use. White foster children in particular 
were more likely to receive psychotropic medication than non-White foster children. However, 
we have yet to establish whether this difference is driven by over-prescribing among white 
youth, under-prescribing among minority youth, or both. We do know that racial and ethnic 
minorities have expressed strong feelings of mistrust and fear towards Western “white medicine” 
(McGuire & Miranda, 2008; Ojeda & Bergstresser, 2008; U.S. Department of Health and Human 
Services [DHHS], 2001). White children may have greater cultural acceptance of medical 
intervention whereas their Black and Hispanic counterparts may harbor greater stigma towards 
mental illness and mental health treatment (Anglin, Link, & Phelan, 2006). In addition, children 
of color may not have the same access to psychotropic medication treatment as their White 
counterparts. Because the studies are limited to descriptive interpretations, a causal statement 
cannot be made for why Black foster youth are less likely to receive psychotropic medication. As 
a precaution, policy-makers should examine the mental health system to ensure that there are no 
barriers to appropriate mental health treatment for children of color. Future studies may look 
further into whether minority youth are not offered or do not accept medication 
recommendations. 
Children in out-of-home placement were also twice as likely to receive psychotropic 
medication than foster children in in-home placements. This trend raises concern that children 
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living in out-of-home placements are over-medicated because of poor systemic oversight or 
because non-familial caretakers may have a preference of relying on medication to calm 
children. Another possible explanation may be that out-of-home placements are in nature a 
traumatic experience and medication may help the child stabilize during periods of transitions. 
Finally, the children in Medicaid systems with primary care case management (PCCM) were less 
likely to receive psychotropic medication than those in fee-for-service systems. In PCCM 
Medicaid systems, the state Medicaid agency employs a primary care provider to approve and 
monitor the care of enrolled Medicaid beneficiaries for a small monthly case management fee. It 
may be that having a primary care provider oversee all the care of the foster child reduces the 
risk of overmedication. Policy-makers may consider this Medicaid model as a means of 
preventing possible over-medication of children in foster care. 
Clinical Relevance  
Different abuse histories had a differential patterns of psychotropic medication use. 
Children with physical abuse were more likely to receive psychotropic mediation, while children 
who were neglected were less likely to be receive such medication. This finding suggests that 
abuse history is relevant information and that clinicians treating emotional and behavioral 
symptoms should be cognizant of this history. According to developmental traumatology 
research, abuse and neglect are considered as a most extreme form of dysfunctional family and 
interpersonal functioning in the spectrum of adverse life circumstances and dysfunctional 
interpersonal and family relationships (De Bellis, 2001). Trauma exposure for children in foster 
care are not only from abuse but also from a host of potentially traumatic events such as 
domestic violence, community violence, socioeconomic disadvantage, homelessness, and 
parental mental illness (including alcohol and substance abuse. Trauma-exposed children have 
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elevated internalizing and externalizing problems that are persistent and make them more unable 
to cope with subsequent, nontraumatic life stressors (Grasso, Ford, & Briggs-Gowan, 2013). This 
paper found that children with behavioral problems were much more likely to receive 
psychotropic medication, especially those with externalizing behaviors. Therefore, it is important 
that childhood trauma, such as abuse, are addressed. Clinicians should be cautious not to overuse 
psychotropic medication as a means of modifying behavior simply to appease caretakers or 
teachers but rather should ensure that children receive appropriate clinical care for their genuine 
mental health needs. Finally, children with fair or poor health were found to be more likely to 
receive psychotropic medication than children with excellent or good health. This finding may 
indicate a possible correlation between health and behavioral or emotional needs. Clinicians 
should consider a holistic approach in the treatment of a child’s mental health and address 
possible physical health needs in their treatment plan. 
Limitations and Strengths 
A core strength of this review is its systematic approach in which clear inclusion criteria 
were developed in accordance with the PRISMA guidelines and quantitative synthesis. This 
study follows a rigorous standard of systematic literature review and meta-analysis on a topic 
that has not been studied using this methodology. Also, many of the correlational analyses had 
low or no evidence of true heterogeneity between studies which may be an indication that the 
various studies share common findings, thus supporting the generalizability of these studies.  
However, findings from the review should be interpreted with several limitations in mind. 
Although a larger sample of studies was identified through the systematic literature review, not 
all of them could be included in the meta-analysis because meta-analysis should be conducted 
only on similar studies. As a result, not all studies could be summarized due to narrow study 
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subjects, diagnoses, and treatment types. The small sample sizes limited the number of studies 
that could be analyzed. Also, because there were so few studies conducted on some sub-
populations/topics, sub-analysis could not be performed. In addition, Cochrane states that the 
EPHPP tool is best conducted by individuals trained on the tool; I did not receive formal training 
on the tool. Another limitation is that the quality assessment was conducted by a single-
investigator which increases the risk of bias. Furthermore, most studies in this area used a cross-
sectional design and only a few took additional measures to reduce bias due to confounding 
variables. Because the studies reviewed were correlational, conclusions could not be drawn on 
causality. The field would benefit from more studies of experimental or quasi-experimental and 
longitudinal study designs.  
A characteristic limitation of systematic review studies and meta-analysis are that studies 
are limited to studies that were published. Therefore, it is possible that unpublished data may 
contradict the findings from published research. However, the funnel plots do not provide 
definitive evidence of publication bias. Finally, studies were evaluated by only one coder which 
is also a limitation of this review. 
Further Considerations and Future Research 
Forty studies examined the use of psychotropic medication for children in foster care 
since 1990, with most analysis involving secondary, administrative data. Some studies involved 
subgroups such as very young foster youth, older foster youth, children treated for ADHD, and 
the use of second-generation anti-psychotic medication. However, limitations of the data 
precluded more detailed comparisons across these specialized sub-groups. To preserve the 
homogeneity of the studies analyzed, a smaller set of studies were summarized through meta-
analysis than the initial pool of studies found through the systematic literature review. Future 
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research is needed to determine whether results from these subgroups can be replicated or 
generalized.  
 There may be different predictors of psychotropic medication use for children in foster 
care than those examined in this review. For example, some studies reported significant positive 
relationship with children in group homes (Breland-Noble et al., 2004; Zima et al., 1999a). 
However, meta-analysis could not be undertaken to confirm this finding due to a small sample 
size (k = 2 studies). Future research is required to examine additional predictors of psychotropic 
medication use for children in foster care: possible predictors that may be of interest may be 
different placement types (such as foster care, therapeutic foster care, kinship care, or residential 
care), various mental health diagnosis, physical disability, as well as parental factors such as 
parent substance abuse or single parent status. 
 The risk of bias analysis conducted through the EPHHP scores indicated that most studies 
conducted in this area are not considered strong in quality. Studies received lower ratings of 
quality because most of the research were descriptive in nature and did not take adequate 
measures to use a controlled comparison group. This research area can be strengthened by 
conducting more experimental studies such as randomized controlled trials. However, because 
this is a sensitive research area involving a particularly vulnerable subject population, most 
studies are conducted retrospectively using secondary, administrative data. When secondary 
datasets are used, these studies can benefit from the use of advanced quasi-experimental study 
methods to mimic a controlled comparison group of a randomized controlled trial. 
 Finally, virtually every study to date was exploratory in nature; only one study identified 
through the systematic literature review examined the causal effects of psychotropic medication 
use on the foster youth. The lack of causal studies is a significant gap and oversight in the 
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research and the field would benefit greatly from understanding the impact of medicating 
children in foster care.   
Conclusions 
 Although there have been many exploratory studies conducted on the use of psychotropic 
medication for children in foster care, generalizability in the findings is limited because of the 
variabilities in the research area such as age, diagnosis, foster care setting, and geography. This 
review confirms prior findings of high use of psychotropic medication for children in foster care. 
Several demographic and policy factors were also found to be associated with elevated risk of 
medication use. Clinicians may be informed by the findings of this review to identify children 
who may be more vulnerable to over-medication or may be overlooked as good candidates for 
medication. Policy-makers may also use the findings of this review to consider areas of policy 
intervention to prevent possible over-medication of children in foster care. The robustness of the 
findings of this review may be limited because some studies were deleted from analysis due to 
specialty foci and the cross-sectional nature of the studies. The review highlights the need for 
experimental/quasi-experimental study designs to examine causal effects of psychotropic 
medication use for children in foster care.  
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PAPER II 
 
PSYCHOTROPIC MEDICATION USE AMONG CHILDREN IN THE FOSTER CARE 
SYSTEM 
 
 
Abstract 
 This study examines the characteristics associated with psychotropic medication use 
among children in foster care. A sample of 30,657 children who entered foster care between 
March 1, 2006 and June 30, 2012 were observed for characteristics that were associated with the 
use of psychotropic medication. One in five children in the study (20.9%) received a 
psychotropic medication during their time in care. Males, Whites, younger children, and those 
with a mental health diagnosis were more likely to receive psychotropic medication. Those 
placed in kinship care were less likely to receive psychotropic medication. Among those who 
were medicated, adjustment disorder was the most commonly diagnosed mental illness and its 
prevalence grew throughout the study period. Stimulants were the most prescribed medication 
and taken by 59.0% of those who received medication. Implications for practice, policy, and 
research are discussed. 
Keywords: Foster care; Psychotropic medication; Administrative data 
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Introduction 
 An estimated 400,540 children are in foster care across the United States (Child Welfare 
Information Gateway, 2013; NIMH, 2009). Children who enter into foster care have experienced 
abuse, neglect, or dependency, and for the safety and well-being of the child, must be taken out 
of their biological home. These experiences are often the most severe forms of trauma known as 
“complex trauma” which refers to a child’s experiences of multiple traumatic events that occur 
within the caregiving system, a social environment that is supposed to be a source of safety and 
stability in a child’s life (Cook, Blaustein, Spinazzola, & van der Kolk, 2003). Not surprisingly, 
given their prior experiences, children in foster care have higher rates of serious emotional and 
behavioral problems (Burns et al., 2004).  
Children in foster care often require mental health intervention to address their emotional 
and behavioral needs. Although pharmacological treatments can be an important component of 
the treatment plan, there seems to be a higher rate of use than would be expected. Paper I, which 
synthesized the findings of the body of literature on the use of psychotropic medication among 
U.S. foster children, found an overall prevalence rate of medication use of 32.9%. An estimated 
13-25% of foster children are prescribed mind- and mood-altering medication vs. 4% in the 
general population, and of those that were medicated, the average number of medications per 
child is 2.55 (Leslie et al., 2010; Zito et al., 2008). Previous Medicaid studies have found that, 
although foster youth represent a very small percent of Medicaid population, relative to other 
Medicaid recipients, the rate of psychotropic medication for children in foster care is 3.5- to 11-
times greater than Medicaid-insured youth not in foster care (DosReis et al., 2001; Zito et al., 
2005).  
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Although it is difficult to find a comparable comparison group for the unique adverse 
circumstances experienced by children in foster care, there is concern that the lack of appropriate 
screening and assessment and/or the limited availability of health care professionals trained to 
provide effective psychosocial therapy may be contributing to the higher rates of medication use 
among foster children rather than actual need (Fernandes-Alcantara, Caldwell, & Stoltzfus, 
2015). Oftentimes psychotropic medication is the sole therapeutic intervention for the child; one 
study found that for nearly 50% of foster children receiving psychotropic medication, it was the 
sole means of addressing the emotional or behavioral problem (Warner, Song, & Pottick, 2014). 
The high use of psychotropic medication to treat emotional and behavioral problems for children 
in foster care has been a pressing problem for child welfare agencies and advocates and is a 
phenomenon that requires greater examination (Daviss, Barnett, Neubacher, & Drake, 2016).  
Children in foster care are considered a vulnerable population and research involving 
these children justifiably requires additional measures to ensure their protection. As a result, 
studies on the use of psychotropic medication among youth in foster care have relied primarily 
on secondary data—typically administrative data. The use of secondary data has many 
advantages, one of which is that investigators are able to conduct analysis with no effect on the 
child. Additionally, using administrative data is cost-effective in that it allows for much larger 
sample sizes than could be amassed through primary data collection, often at a far lower cost. In 
addition, administrative data are resilient to many of the pitfalls of primary data collection such 
as investigator bias and social desirability bias. As is the case with this study, using 
administrative data may also enable the researcher to capture the entire study population of 
interest. This feature mitigates the risk of sampling bias in which the sample would not 
accurately represent the larger population of interest. 
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 This study sought to use linked administrative datasets to rigorously examine the use of 
psychotropic medication among youth in foster care by analyzing its prevalence and 
characteristics of users both cross-sectionally as well as longitudinally. This study utilized a 
linked dataset to examine the use of psychotropic medications among children who entered 
foster care in North Carolina between March 2006 and June 2012. The dataset was constructed 
by linking the North Carolina’s child welfare administrative records (also known as the Services 
Information System [SIS]) with the Medicaid claims database (also known as the Eligibility 
Information System [EIS]) for medical and mental health services received by the foster youth. 
These databases provide not only child information such as gender, race, and abuse history, but 
also what diagnosis they received and medications that were billed to Medicaid for their 
treatment. A descriptive analysis was performed to understand the population of foster children 
who receive psychotropic medication and the relationship between medication use and various 
predictor variables. 
Literature Review 
There are a wide range of estimates on the prevalence of the use of psychotropic 
medication among children in foster care derived from an assortment of study designs. One study 
of school-aged foster children from Los Angeles County found a prevalence rate of 13% (Zima 
et al., 1999) whereas a 13-state convenience sample survey of children in therapeutic foster care 
and residential treatment centers found a prevalence rate of 82% (Baker et al., 2007). The 
variation in prevalence estimates represent diverse study populations (e.g., preschool-aged 
children, children with ADHD, antipsychotic medication users exclusively, group care residents) 
and different study designs (e.g., case study reviews, cross-sectional data, longitudinal studies). 
Raghavan et al. (2010) also found psychotropic medication rates differed between states. 
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Predictors of Psychotropic Medication Use Among Foster Youth 
Prior quantitative studies among children in foster care found that experiences of 
abandonment, emotional abuse, and neglect were not significant predictors of psychotropic 
medication use, although there were some evidence suggesting an association of physical abuse 
and sexual abuse to medication use (Leslie, 2011; Raghavan et al., 2012, 2014a, 2014b). 
Children with prescribed medication were more likely to be White, male, older and in poorer 
health (Leslie et al., 2011; Raghavan et al., 2010, 2012, 2014a, 2014b; Steele et al., 2008; 
Breland-Noble et al., 2004; Zima et al., 1999).  
Most studies found that children in group homes or out-of-home placements were more 
likely to receive psychotropic medication with the exception of one study that found no 
significant association between out-of-home placement and medication (Breland-Noble et al., 
2004; Leslie et al., 2011; Raghavan et al., 2010, 2012, 2014a, 2014b). Differences in findings 
may be due to dissimilar sources for medication information; some studies relied heavily on 
Medicaid claims data, others collected this information through survey data. County 
characteristics such as total pediatrician ratio, psychiatrist ratio, poverty, or rurality was not 
associated with psychotropic medication use (Leslie et al., 2011; Raghavan et al. 2010, 2012, 
2014a, 2014b).  
Most studies found that children with borderline scores on the internalizing (e.g., 
depression and anxiety) and externalizing (acting out behaviors, e.g., aggression) subscales on 
the Child Behavioral Check List (CBCL) were more likely to receive psychotropic medication 
(Breland-Noble et al., 2004; Leslie et al., 2011; Raghavan et al., 2010, 2012, 2014a, 2014b). 
However, Zima et al. (1999) did not find a significant association with clinician diagnosis with 
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impairment and psychotropic medication use although this study did not utilize large, 
administrative or national survey data.  
Medication Types 
Studies that looked at the type of medication prescribed to foster children found that the 
most frequently prescribed psychotropic medications were antidepressants (57%), ADHD drugs 
(56%) and antipsychotics (53%) (Zito et al., 2008a). For those diagnosed with ADHD or major 
depression, stimulants were the most prescribed medication but for those diagnosed with 
psychotic disorder not otherwise specified, antipsychotics were most frequently prescribed (Zima 
et al., 1999). The use of a specific psychotropic medication class varied little by diagnostic 
grouping (Zito et al., 2008a). 
Gaps in the Literature 
Many of the studies conducted in this area were cross-sectional which are unable to 
examine changes over time. Additional research with a large sample size and longitudinal 
analysis would further strengthen the understanding of psychotropic medication practices in the 
child welfare system. Furthermore, administrative datasets are underused in previous studies. 
Administrative data are a rich source of information that can be used to examine psychotropic 
medication use in foster care. This study utilized administrative data which provided extensive 
information on individuals over extended periods of time and with multiple data points. Linked 
administrative data were used not only to provide an estimate of the prevalence of psychotropic 
medication use in foster care but also what characteristics were associated with medication use 
(e.g., gender, age, abuse history, and rural/urban environment). A state-wide administrative data 
analysis not only provides more evidence on the phenomenon of interest but is also a form of 
potential validation for the findings of previous studies that have used different study designs.  
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Method 
Design and Data Sources 
This paper conducted a descriptive analysis as well as a retrospective longitudinal cohort 
design study to examine the association between individual and contextual-level factors and 
medication use among children in foster care. The study used a linked dataset of the North 
Carolina’s child welfare administrative records and the Medicaid service claims file. Foster care 
experiences data such as entries, placements, and exits from foster care; payments for children in 
licensed care; and investigations and assessments of reports of child maltreatment were extracted 
from the foster care administrative dataset, also known as the Services Information System (SIS) 
data files. The Medicaid service claim files included outpatient and physician claims and 
prescription drug claims as well as the International Classification of Diseases and Related 
Health Problems, Ninth Revision (ICD-9) diagnosis and procedure codes.  
Study Sample  
The study population included all children who entered foster care in North Carolina 
between March 1, 2006, and June 30, 2012. The analysis was limited to the first spell of a child’s 
placement authority, as having more than one placement authority is an anomaly. A “spell” is the 
period of time that a child is in care from the time they enter foster care to the time they exit care. 
Children who had a first spell before the timeframe were excluded from the sample. Overall, 
90.2% of the sample had only one spell, 8.8% had two spells, 1.0% had three spells, 0.07% had 
four spells and 0.02% had 5 spells. Children who exit the child welfare system and re-enter at 
another date are a small and atypical sub-population which would require separate analysis.  
The sample was divided into a treatment group, composed of children in foster care who 
received one or more psychotropic medications (i.e., antidepressant, antipsychotic, mood 
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stabilizer, anxiolytic, stimulant, or alpha-adrenergic agonists [AAAs]), and a control group of 
children in foster care who did not receive psychotropic. The two groups were identified by the 
presence or absence of at least one claim of psychotropic medication given as indicated on the 
Medicaid claims dataset while the child was under child welfare placement authority. 
Measures 
Table 5 includes a description of all variables and pertinent references. The covariates 
have been carefully selected from the literature (reviewed above) and data availability to 
describe the medicated foster care population. Sociodemographic characteristics and abuse and 
foster care experience information were collected from foster care administrative records. 
Although the dataset categorizes race/ethnicity as White (non-Hispanic), Black (non-Hispanic), 
Hispanic, Asian, Indian, Pacific Islander, and Unknown, in the analysis, race/ethnicity was 
grouped as White (non-Hispanic) , Black (non-Hispanic), Hispanic, and all other groups and 
mixed races were categorized as Other because of small cell sizes (less than 2% was American 
Indian, and less than 0.3% was Asian).  
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Table 5. Variables used in this research 
Variables Description 
Gender Male or female. 
Age Age was calculated for each month the child was in child welfare custody using date of 
birth. 
Race White (non-Hispanic), Black (non-Hispanic), Hispanic, and Other. 
Abuse history A set of binary variables to describe child’s reason for entering care: (1) Physical abuse, 
(2) Sexual abuse, (3) Neglect, and (4) Other. Other reasons for entry into care not related 
to abuse include parent alcoholism, abandonment, child behavior, coping, parent death, 
parent drug abuse, child drug use, incarceration, child disability, and inadequate housing. 
A child may have one or more reasons for entering care. 
Placement type A set of variables that describes the child’s living arrangement. The four primary 
placement types are (1) foster homes (which includes specialized foster homes), (2) 
therapeutic foster home, (3) kinship care (which includes adoptive relative home, relative 
foster home, unpaid relative, specialized relative family, adoptive foster home, and non-
relative adoptive home), and (4) group placement (which includes large residential group 
facilities, large treatment group facilities, residential schools, small residential group 
homes, and small treatment group homes). All other living arrangements are categorized 
as (5) “Other” (which includes children’s camps, emergency shelters, hospitals, 
independent living, jail/detention, legal guardian, maternity home, other court approved 
placement, unknown, parents, respite care, trial home visit, juvenile justice residential 
facility, and unknown/missing).  
Physical disability Indicator variable for the presence of a physical disability. 
Parental substance 
abuse 
Indicator variable for whether the parent has a substance abuse disorder. 
Single parent 
household 
Indicator variable for whether the child’s biological household is single parent. 
Entry Cohort The calendar year the child entered foster care: 2006, 2007, 2008, 2009, 2010, 2011, and 
2012. 
Diagnosis Mental health diagnoses in the Medicaid dataset are categorized in accordance with the 
Diagnostic and Statistical Manual of Mental Disorder IV-TR and coded using the 
International Classification of Diseases, Ninth Revision (ICD-9) classification. Ordered 
hierarchically from most severe to least severe beginning with (1) schizophrenia and 
other psychoses, (2) pervasive developmental disorders and mental retardation (PDD-
MR), (3) bipolar disorder, (4) disruptive disorders, (5) attention-deficit hyperactivity 
disorder (ADHD), (6) depressive disorders, (7) anxiety disorders, (8) adjustment 
disorder, (9) communication or learning disorders, and (10) any other psychiatric 
diagnosis. 
Psychotropic 
Medication 
A set of variables that identifies medication according to the American Hospital 
Formulary Services pharmacologic therapeutic classification system: (1) antidepressants, 
(2) antipsychotics, (3) moodstabilizers, (4) anxiolytic, (5) stimulants and (6) alpha-
adrenergic agonist (AAA). 
Rurality Indicator variable for whether the child’s county of placement is classified as 
metropolitan or non-metropolitan according to the 2013 Urban Influence Code. 
Clinical characteristics such as diagnosis and medication were collected from Medicaid 
claims data. To account for possible cohort effects in which temporal experiences may influence 
the sample selection or experiences, entry cohort was added as a control variable. Entry cohort is 
the calendar year (January to December) that the child enters foster care. The 2006 and 2012 
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entry cohorts do not include all 12 months. Due to the availability of data and data access, the 
study window only allows for entries after March 1, 2006 and before July 1, 2012.  
Mental health diagnosis. Mental health diagnosis was used in the descriptive analysis 
and as a statistical control in the longitudinal studies. Mental health diagnoses in the Medicaid 
dataset are categorized in accordance with the Diagnostic and Statistical Manual of Mental 
Disorder IV-TR and coded using the International Classification of Diseases, Ninth Revision 
(ICD-9) classification. This paper applied the mental health categorizations used in prior related 
studies, in which mental health diagnoses are ordered hierarchically and from most severe to 
least severe beginning with schizophrenia and other psychoses and followed by pervasive 
developmental disorders and mental retardation (PDD-MR), bipolar disorder, disruptive 
disorders, attention-deficit hyperactivity disorder (ADHD), depressive disorders, anxiety 
disorders, adjustment disorder, communication or learning disorders, and any other psychiatric 
diagnosis (Olfson, Blanco, Liu, Moreno & Laje, 2006; Zito et al., 2013). The most severe 
diagnosis that a child received was accounted for in order to prevent overlap of diagnostic 
categories (see Appendix C). 
Psychotropic medication.  Psychotropic medications were identified within the 
Medicaid dataset using the American Hospital Formulary Services (AHFS) pharmacologic 
therapeutic classification system (see Appendix B). Antidepressants (AHFS numeric codes 3 – 8 
and 10) include serotonin reuptake inhibitors (SRIs), tricyclics (TCAs), monoamine oxidase 
inhibitors (MAOIs), and other antidepressants (e.g., trazodone hydrochloride, bupropion, and 
mirtazapine). Antipsychotics (codes 1, 2, 8, and 9) include both typical (e.g., chlorpromazine 
hydrochloride, fluphenazine, hydrochloride, mesoridazine) and atypical (e.g., risperidone, 
olanzapine, quetiapine) medications. Mood stabilizers (codes 16 and 20) include anticonvulsants 
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(e.g., carbamazepine, valproate sodium, gabapentin) and lithium. Anxiolytics (codes 10, 18, 19, 
and 21) include benzodiazepines (e.g., clonazepam) and nonbenzodiazepines (e.g., busprione). 
Stimulants (codes 11 – 15) include methylphenidate, amphetamine, and pemoline as well as 
other ADHD medications (e.g., atomoxetine). The final pharmacologic therapeutic class is alpha-
adrenergic agonists (AAAs; code 17), examples of which include clonidine hydrochloride and 
guanfacine hydrochloride. Some of the numeric codes appear in more than one therapeutic class 
because certain drugs have more than one active ingredient. For this study, the medication 
variables were coded as present or not present (1 or 0) for each month the child received the 
medication. The medication start date was determined by claim date; medication end date was 
determined by taking the start date and adding the number of days of medication supplied when 
prescribed. 
Rurality. Rurality was measured by the 2013 Urban Influence Codes which classify 
counties into two metropolitan and 10 non-metropolitan categories. For counties containing 
metropolitan areas, classification was based on population size of that metropolitan area. For 
non-metropolitan counties, classification was based on the size of that county’s largest city or 
town and its proximity to metro- and micropolitan areas (Economic Research Service, 2013).  
Statistical Analysis 
Descriptive analysis including univariate analysis such as frequency distributions and 
measures of central tendency and variation were conducted on the linked dataset. The chi-square 
was used to determine differences in characteristics of the medicated vs. non-medicated samples 
as well as the diagnosed vs. non-diagnosed samples. The chi-square test of linear trend was used 
to determine whether demographic and contextual characteristics of children who were 
medicated changed over time.  
58 
Generalized linear modeling (GLM) using a logit link examined the association between 
individual and contextual-level factors and medication use. GLM is the appropriate analysis for 
longitudinal and hierarchical data with repeated binomial outcomes because it is robust against 
assumptions of normal distribution and homoscedastic errors associated with categorical, non-
normally distributed response variables such as binary data (McCullagh & Nelder, 1989). This 
procedure generates unbiased estimates as well as correct standard errors.  
The SAS GLIMMIX procedure was used in this analysis. Unlike other procedures such 
as GENMOD and PROC MIXED, GLIMMIX allows for the response to have a non-Gaussian 
distribution with arbitrary skewness and kurtosis and provides for random effects (Littel, 
Miliken, Stroup, Wolfinger, & Schanbenberger, 2006). In addition, the GLIMMIX procedure can 
simultaneously account for the non-normality of the distributions and the correlations often 
found in multiple outcomes without losing power (Littel et al., 2006). P-values less than or equal 
to 0.05 were used to indicate statistically significant differences. All analysis was conducted 
using SAS, version 9.3 (SAS, 2011).  
Results 
Of the original 54,571 foster children in the dataset, 23,890 were eliminated from the 
study for not entering care between March 2006 and June 2012. Birthdates that were recorded as 
occurring after the placement authority date but within 7 days of that date, were assumed to be 
clerical errors since a child cannot be placed in authority before he/she is born; in these cases, the 
placement authority date was adjusted to match the birthdate. If age of entry was still less than 0 
years or greater than 19 years after data cleaning of birthdates, those cases were eliminated. Only 
twenty-four foster (24) children (or 0.0008%) were excluded for incorrect date of birth.  
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The final sample included 30,657 foster children (see Figure 3). Although 5,046 (or 
16.5% of the sample) had no Medicaid claims during the study period, it is likely that these 
children did not receive any medical services rather than having alternate health payment 
arrangements since all youth in foster care are categorically covered by their state’s Medicaid 
program; therefore, these children were considered nonusers of psychotropic medication (Geen, 
Sommers, & Cohen, 2005).  
 
Figure 3. Dataset construction flow chart 
After cleaning placement authority spells in the dataset, most children in the merged 
dataset had one placement authority spell (n = 27,663 or 90.2%). Only the first spell was used for 
analysis because those with two or more spells are likely a special sub-population that requires 
separate analysis.  
Study Sample 
Of the 30,657 individual children who entered foster care between March 1, 2006, and 
June 30, 2012, 20.9% (or 6,420 children) received at least one psychotropic medication at some 
point during their placement. There were slightly more males than females in the medicated 
sample whereas there were fewer males than females in the non-medicated sample (p <.0001). 
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For the racial makeup of the medicated and non-medicated samples, there were more 
proportionately more Whites in the medicated sample than non-medicated sample (54.8% vs. 
46.5%). There were proportionately more minorities in the non-medicated sample with the 
largest difference in the Hispanic ethnicity group which made up 5.6% of the medicated sample 
compared to 9.1% in the non-medicated sample (p <.0001). The racial differences were 
statistically significant between the two groups for all categories. 
The medicated and unmedicated groups differed greatest in age of entry: the medicated 
group was on average 3 years older than the non-medicated group: the average age of entry for 
the medicated group was 10.7 years compared to 5.8 for the non-medicated group (p <.0001). In 
categorical ages, 56.6% of the unmedicated sample were under 5 compared to 12.6% of the 
medicated sample (p <.0001). Older children made up more of the medicated sample than the 
unmedicated sample in the 5 to 9 years old category (29.6% vs. 19.0%), 10 to 14 years old 
category (35.4% vs. 14.9%), and 15 to 19 years old category (22.4% vs. 9.5%). 
Foster care experiences differed statistically between the medicated and non-medicated 
samples. Placements in therapeutic foster homes (31.3% vs. 5.7%), residential care (34.1% vs. 
7.8%), and other placements (48.9% vs. 36.8%) were significantly more common in the 
medicated sample than the unmedicated sample. In contrast, there were more non-medicated 
children in kinship care than in the medicated group (54.1% vs. 42.0%). The difference was 
statistically significant for the two groups in all placement types. 
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Table 6. Sample description (N = 30,657) 
 Medicated 
(N =6,420)a 
 Non-Medicated 
(N = 24,237)b 
 Statistical Analysis 
n % 
(SD) 
 n % 
(SD) 
 Χ2  df p-value 
Gender       114.3 1 <.0001 
Female 8,091 48.2  7,146 51.5     
Male 8,695 51.8  6,725 48.5     
Race          
White 3,520 54.8  11,281 46.5  139.5 1 <.0001 
Black 2,083 32.5  8,376 34.6  10.1 1 <.01 
Hispanic 360 5.6  2,202 9.1  80.2 1 <.0001 
Other 457 7.1  2,378 9.8  43.9 1 <.0001 
Overall Age          
     Mean (SD) 11.8 (4.6)  6.4 (5.5)  -79.9 c  <.0001 
Age at foster care entry          
    Mean (SD) 10.7 (5.6)  5.8 (5.4)  -74.5c  <.0001 
    Categorical          
     0–4 years   807 12.6  13,722 56.6  4,065.2 1 <.0001 
     5–9 years 1,900 29.6  4,607 19.0  54.3 1 <.0001 
     10–14 years 2,273 35.4  3,603 14.9  576.4 1 <.0001 
     15–19 years 1,440 22.4  2,305 9.5  2,340.3 1 <.0001 
Abuse history          
     Physical abuse 578 9.0  2,129 8.8  0.3 1 NS 
     Sexual abuse 362 5.6  845 3.5  62.2 1 <.0001 
     Neglect 4,744 73.9  19,726 81.4  176.9 1 <.0001 
     Other 1,486 23.2  3,879 16.0  179.3 1 <.0001 
Placement type          
     Foster care 3,353 52.2  13,541 55.9  27.2 1 <.0001 
     Therapeutic FC 2,007 31.3  1,390 5.7  3,356.7 1 <.0001 
     Kinship care 2,696 42.0  13,112 54.1  297.8 1 <.0001 
     Residential care 2,186 34.1  1,894 7.8  3,028.0 1 <.0001 
     Other 3,141 48.9  8,917 36.8  313.2 1 <.0001 
Entry cohort       139.9 6 <.0001 
     2006 1,007 15.7  3,908 16.1     
     2007 1,175 18.3  4,190 17.3     
     2008 1,075 16.7  3,601 14.9     
     2009 1,006 15.7  3,388 14.0     
     2010 1,005 15,7  3,490 14.4     
     2011 860 13.4  3,614 14.9     
     2012 292 4.6  2,046 8.4     
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Table 6. Continued 
 Medicated 
(N = 6,420)a 
 Non-Medicated 
(N = 24,237)b 
 Statistical Analysis 
n % 
(SD) 
 n % 
(SD) 
 Χ2  df p-value 
Diagnosis 6,206 96.7  10,623 43.8  5,722.7 1 <.0001 
     Schizophrenia 132 2.1  30 0.1  360.5 1 <.0001 
     PDD/MR 324 5.1  179 0.7  583.7 1 <.0001 
     Bipolar disorder 676 10.5  120 0.5  2,020.8 1 <.0001 
     Disruptive disorder 2,429 37.8  2,063 8.5  3,489.8 1 <.0001 
     ADHD 1,494 23.3  707 2.9  3,155.4 1 <.0001 
     Depressive disorders 325 5.1  427 1.8  231.1 1 <.0001 
     Anxiety disorders 204 3.2  816 3.4  0.6 1 NS 
     Adjustment disorder 237 3.7  2,311 9.5  227.4 1 <.0001 
     Communication or LD 203 3.2  2,481 10.2  318.0 1 <.0001 
     Other 1,489 6.1  182 2.8  107.8 1 <.0001 
Physical Disability 106 1.7  167 0.7  53.2 1 <.0001 
Parents          
    Substance Abuse 1,667 26.0  8,207 33.9  144.9 1 <.0001 
    Single parent 3,801 59.2  13,877 57.3  7.9 1 <.01 
Rurality       2.2 1 NS 
    Metropolitan 4,701 73.2  17,524 72.3     
 Non-metropolitan 1,719 26.8  6,713 27.7     
 
a 20.9% of total sample 
b 79.1% of total sample 
c Satterwhaite t-test of unequal variance 
 
NOTE.  ─ ADHD =Attention deficit and hyperactivity disorder; FC = Foster care; LD = Learning 
disorder; PDD/MR = Pervasive developmental disorder/mental retardation; SD = Standard deviation; 
NS = Non-significant at p<.05 
 
The presence of a mental health diagnosis was significantly higher in the medicated 
sample than in the non-medicated sample: Nearly all children in the medicated group had any 
documented diagnosis (96.7%) whereas less than half (43.8%) of the non-medicated sample had 
any documented diagnosis. The three most diagnosed illnesses for the medicated group were 
disruptive disorder (found in 37.8% of the sample), ADHD (23.3%), and bipolar disorder 
(10.5%). The three most diagnosed mental illnesses in the non-medicated group were 
communication or learning disorder (10.2%), adjustment disorder (9.5%), and disruptive disorder 
(8.5%). Schizophrenia, PDD/MR, and bipolar disorders were very rare in the unmedicated 
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children (under 1%). The treatment and comparison group were statistically different among all 
diagnoses except for anxiety disorder; medicated children had higher rates of diagnosis in each 
category except for adjustment disorder (3.7% vs. 9.5%) and communication or LD (3.2% vs. 
10.2) (see Table 6). 
The medicated and unmedicated group did not differ in rurality. The proportion of 
children in each sample in each of the seven entry cohort years was relatively similar except for 
in 2012, which had a smaller window of observation. There did not seem to be a linear trend of 
medication use by entry cohort by observing the changes in proportion. Although there was 
statistical significance in difference between the two groups, results from statistical testing 
should be interpreted with caution with large sample sizes. 
Medication Prescribed and Polypharmacy 
Among the medicated sample, three out of five children had a prescription for a stimulant 
(59.0%). After stimulants, antidepressants (56.2%) and antipsychotics (42.0%) were the next 
most commonly prescribed medications. Mood stabilizers and AAAs and were each prescribed 
to about a quarter of the medicated foster children (24.7% and 23.4% respectively. Appendix B 
describes medications by drug class and the prescribed indications for each. When a child was 
medicated, he or she was often prescribed more than one type of medication: children received 
medications, on average, from 1.7 medication classes (SD = 0.9), with concomitant prescriptions 
from up to 6 different medication classes at a time (see Table 7).  
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Table 7. Medications prescribed by type (N = 6,420) 
Medication n % 
    Antidepressant 3,607 56.2 
    Antipsychotic 2,699 42.0 
Moodstabilizer 1,584 24.7 
Anxiolytic 277 4.3 
Stimulant 3,787 59.0 
AAA 1,500 23.4 
Number of Medication   
     Mean (SD) 1.7 (0.9) 
     Range (Min, Max) (1, 6)  
NOTE.  ─ AAA = Alpha-adrenergic agonists; SD = Standard deviation. 
 
 Some children received more than one class of medication at a time, a practice known as 
polypharmacy. Table 8 shows the five most common combinations of medication classes 
prescribed. Some children may have had more than one combination type. Most of the between-
medication classes involved some combination of antidepressants and/or stimulants. In fact, the 
most common form of polypharmacy was a combination of antidepressant and stimulant (16.7% 
of the medicated sample). Among the most common forms of polypharmacy were a combination 
of three different medication classes which consisted of antidepressants, antipsychotics, and 
stimulants received by 8.7% of the medicated sample. 
Table 8. Most common between-medication class combinations (N=6,420) 
 
n 
% of medicated 
children 
Antidepressant/stimulant 1,070 16.7% 
Antidepressant/antipsychotic 1,010 15.7% 
Antipsychotic/stimulant 772 12.0% 
Stimulant/AAA 624 9.7% 
Antidepressant/antipsychotic/stimulant 557 8.7% 
NOTE.  ─ AAA = Alpha-adrenergic agonists 
Use of Medication by Abuse History 
 Medication prescribed was examined by abuse type (see Table 9). Stimulants, 
antidepressants, and antipsychotics were the most commonly prescribed medication classes 
65 
regardless of abuse history type. Children who were abused sexually had the highest levels of 
any medication use (30.0%) and had the highest levels of antidepressant use; 19.1% of sexually 
abused children received antidepressants.  
Table 9. Medication prescribed by abuse type 
 Physical abuse 
(n=2,707) 
Sexual abuse 
(n=1,207) 
Neglect 
(n=24,470) 
Other 
(n=5,365) 
Stimulant 11.5% 17.6% 12.1% 13.8% 
AAA 5.8% 7.3% 4.9% 5.0% 
Antidepressant 10.8% 19.1% 10.3% 18.3% 
Moodstabilizers 6.4% 7.8% 4.4% 8.4% 
Anxiolytics 1.1% 2.0% 0.8% 1.5% 
Antipsychotic 8.3% 13.7% 7.7% 14.1% 
Any 21.4% 30.0% 19.4% 27.7% 
NOTE.  ─ AAA = Alpha-adrenergic agonists 
Use of Medication by Diagnosis 
Table 10 provides information on the types of medication prescribed for children with 
specified diagnoses. Overall, 36.9% of children with any mental health diagnosis received some 
form of psychotropic medication. The three most prescribed psychotropic medications overall 
were stimulants (22.2%), antidepressants (21.1%), and antipsychotics (15.7%). Most children 
diagnosed with bipolar disorder or schizophrenia received some form of medication (84.9% and 
81.5% respectively). The most frequently diagnosed serious mental illness was disruptive 
disorder (n = 4,492). Of the children diagnosed with disruptive disorder, 34.4% were prescribed 
a stimulant; 34.0% received antidepressants, and 25.6% received an antipsychotic.  
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67 
Changes in the Demographics of Medicated Population Over Time  
Table 11 shows a series of annual, cross-sectional analysis to demonstrate how the 
demographic of medicated children changed throughout the study period. Over the course of the 
study, the proportion of children on psychotropic medication from the entire population 
increased from 12.2% in 2006 to 25.5% in 2012 (p < .0001). Proportion of medicated sample 
were steady through the years on gender; race/ethnicity; rurality; history of physical, sexual, or 
other abuse; physical disability or parental substance abuse. However, the average age increased 
by about half a year from 2006 to 2012 from 11.9 (SD = 5.7) to 12.4 (SD = 4.5). The proportion 
of children under 5 years increased over time (3.8% to 5.6%). The proportion of children 
between the ages of 15 and 19 years also increased from 27.7% to 37.7%. Less children were 
between the ages of 10 and 14 years over time (from 40.2% in 2006 to 30.0% in 2012).  
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Children who experienced abuse made up a larger proportion of the medicated sample 
over time (from 71.8% in 2006 to 75.4% in 2012). The proportion of children on medication 
placed in therapeutic foster care was the only group that experienced a growth over time (from 
20.2% to 28.7%). There was a steady decrease in the proportion of medicated children placed in 
group homes from 31.1% in 2006 to 22.3% in 2012 (see Figure 4).  
 
Figure 4. Trends in medication use by placement type over time 
Most children who were medicated had a mental health diagnosis and the percentage of 
children on psychotropic medication without a documented mental health diagnosis decreased 
during the study period. There were statistically significant increases in the diagnoses of 
schizophrenia, pervasive developmental disability/mental retardation, bipolar disease, and 
disruptive disorder. On the other hand, there were statistically significant decreases in the 
diagnoses of ADHD, depression, anxiety, adjustment disorder, and “other.” There were no 
statistically significant changes in the diagnoses of learning disorder throughout the study period 
(see Figure 5).  
0
5
10
15
20
25
30
35
40
45
50
Foster home* Therapeutic
foster home*
Kinship care* Group home*      Other*
P
er
ce
n
ta
ge
 o
f 
M
ed
ic
at
ed
 P
o
p
u
la
ti
o
n
Placement Type
2006 2007 2008 2009 2010 2011 2012
* p ≤ .05
71 
 
Figure 5. Trends in diagnosis over time 
Year to year, stimulants were consistently the most prescribed medication, with more 
than half of the medicated children prescribed stimulants during every year of the study period 
with the exception of a drop in 2012 (see Figure 6). The percentage of children prescribed 
antipsychotic medication peaked in 2010 then experienced a decreased to about 2006 levels.  
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Figure 6. Medication prescribed over time 
Predictors of Psychotropic Medication Use 
Table 12 presents the odds ratios and 95% confidence intervals from the generalized 
linear mixed model predicting psychotropic medication use among foster youth. A time variable 
was included to account for time and although it was statistically significant, because the 
unadjusted odds ratio was so close to one (1), the effect of time can be considered clinically 
insignificant. Males, Whites, and children between the ages of 5 and 14 years of age were all 
more likely to receive psychotropic medication. Children under 5 years were the least likely to 
receive medication than older adolescents (OR = 0.45). Other than a mental health diagnosis, 
having a physical disability increased the odds of receiving psychotropic medication the most by 
over 200% (OR = 3.26, p < .0001). Children living in metropolitan areas had a 24% higher odd 
of receiving a psychotropic medication than children living in rural areas where children with a 
history of neglect or other abuse had smaller odds of being medicated (OR = 0.71 and OR = 0.67 
respectively). Analysis was also conducted at the placement level. Children placed in foster 
homes, therapeutic foster homes, or residential group homes had a higher probability of being 
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medicated than those living in kinship care with more restrictive placements having higher odds 
of medication. 
Table 12. Estimated OR and 95% CI medication use for medicated children in foster care (N = 
30,657) 
 OR 95% CI p-value 
Time 1.01 1.01, 1.01 <.0001 
Individual-level factors    
Gender    
Male (Ref. Female) 1.27 1.24, 1.30 <.0001 
Race    
Black (Ref. White) 0.67 0.66, 0.69 <.0001 
Hispanic (Ref. White) 0.65 0.63, 0.68 <.05 
Other (ref. White) 0.95 0.91, 0.99 <.0001 
Age in years    
 0-4 0.45 0.43, 0.47 <.0001 
 5-9 1.42 1.37, 1.46 <.0001 
 10-14 1.35 1.31, 1.38 <.0001 
 15-19 1.00 - - 
    Physical disability 3.26 2.96, 3.59 <.0001 
    Parental substance abuse 0.93 0.91, 0.96 <.0001 
    Single parent 0.91 0.89, 0.93 <.0001 
Abuse history    
 Physical abuse 1.16 1.11, 1.20 <.0001 
 Sexual abuse 0.96 0.91, 1.00 <.05 
 Neglect 0.71 0.66, 0.76 <.0001 
 Other 0.67 0.62, 0.72 <.0001 
Placement type    
 Foster home 1.34 1.30, 1.38 <.0001 
 Therapeutic foster home 2.92 2.82, 3.02 <.0001 
 Residential group home 3.12 3.04, 3.27 <.0001 
 Kinship care 1.00 - - 
 Other 1.06 1.02, 1.09 <.01 
Mental health diagnosis    
Schizophrenia 146.92 133.61, 161.55 <.0001 
PDD; mental retardation 93.97 87.75, 100.63 <.0001 
Bipolar disorder 137.39 128.75, 146.60 <.0001 
Disruptive disorder 52.79 49.92, 55.82 <.0001 
ADHD 84.49 79.80, 89.47 <.0001 
Depressive disorders 26.83 25.00, 28.80 <.0001 
Anxiety disorders 11.25 10.44, 12.12 <.0001 
Adjustment disorder 3.23 2.97, 3.51 <.0001 
Communication and LD 6.05 5.57, 6.56 <.0001 
Other 6.29 5.78, 6.84 <.0001 
None 1.00 - - 
Entry cohort 1.00 0.98, 1.00 <.01 
County-level factors    
Rurality    
Metropolitan (ref. Rural) 1.24 1.02, 1.51 <.05 
Note. ADHD = Attention-Deficit Disorder/Attention-Deficit/Hyperactivity Disorder; CI = Confidence 
Intervals; LD = Learning Disorder; OR = Odd ratio; PDD/MR = Pervasive Developmental Disorder/Mental 
Retardation. 
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A mental health diagnosis was the greatest predictor in the receipt of psychotropic 
medication. Any mental health diagnosis was a statistically significant predictor or the child’s 
medication use but the odds of receiving medication for children with the more serious diagnoses 
of schizophrenia, PDD/mental retardation, bipolar disorder, disruptive disorder, or ADHD were 
extremely high.  
Additional analysis was conducted to examine the interaction of diagnosis and placement 
type as the influence of placement on medication may vary on diagnosis. With five categories of 
placements and eleven categories of diagnosis (including no diagnosis), there would have been 
fifty-five combinations of interactions. In order to simplify the analysis and in efforts of 
parsimony, interaction analysis condensed the diagnosis into three categories: severe psychotic 
disorder (i.e., schizophrenia, PDD/MR, and bipolar disorder), non-severe psychotic disorder (i.e., 
disruptive disorder, ADHD, depressive disorders, anxiety disorders, adjustment disorder, 
communication and LD, and other), and none (i.e., no mental health diagnosis). Appendix B 
shows the effect size and significance level of only the main effects (Model 1) and a model with 
placement by mental health diagnosis interaction term (Model 2). The interaction term of 
placement type by mental health diagnosis was statistically significant. Analysis of the 
interaction term revealed that for each of the out-of-home placements, those with a mental health 
disorder (both severe psychotic and non-severe psychotic disorder) were more likely to receive 
medication than those without a mental health disorder or those living in other placements.  
Discussion 
In this statewide population of foster children who entered care from March 2006 to July 
2012, about 20% received a psychotropic medication during their time in care which is within 
the range of reported rates from recent US national studies (13.% to 25%; Raghavan et al., 2012; 
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Raghavan et al., 2014a). However, unlike other studies that have limited their sample to those 
over five years of age, our study included the entire foster care population. The inclusion of very 
young children in our study may have lowered the rate of psychotropic medication compared to 
the prevalence rates estimated from other studies. 
Over the study period, the average age of children who received psychotropic medication 
increased by about half a year. There were several findings that were consistent with previous 
studies (Breland-Nobel et al., 2004; Leslie et al., 2011; Raghavan et al. 2010, 2012, 2014a, 
2014b). In general, males and Whites were more likely to receive psychotropic medication. The 
differences in gender may be due to variations in symptomatology: that is, males and females 
may express their mental illness (Needham, 2009; Silverstein et al., 2013; Wagener, Baeyens, & 
Blairy, 2016). Differences in the symptomatology of mental illness by gender may result in 
misdiagnosis and make appropriate treatment more challenging. Some studies that were not 
specific to child welfare populations have explained racial/ethnic differences on lack of health 
insurance and not having a usual source of medical care (Kirby, Hudson, & Miller, 2010); 
however, this explanation does not explain differences within the child welfare population as 
children in foster care are automatically entitled to Medicaid through Title IV-E of the Social 
Security Act (Centers for Medicare and Medicaid Services [CMS], 2014) and often required a 
comprehensive physical examination upon entry (Leslie et al., 2003). Others have suggested that 
the racial/ethnic differences were due to culturally mediated health beliefs and perceptions 
(Cooper et al., 2003). Future studies should examine the role of culture on health beliefs and 
decisions among the foster youth population.  
Children who had physical disabilities were also more likely to receive psychotropic 
medication. This may be because these children with greater health needs may be receiving 
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greater attention from health professionals, thereby increasing the likelihood of receiving 
medication for their mental health needs. Prior studies used different measurements for health: 
for example, Raghavan et al., (2012) used a caretaker assessment to measure the physical health 
of the child whereas our measurement was the social worker’s visual assessment of physical 
disability. The two constructs may not be equivalent, but the result of health is still the same. 
Additional analysis was performed on the physically disabled population and found that they 
were more likely to be physically abused (13.2% vs. 8.8%; p < .05), more likely to be in 
therapeutic foster care (21.2% vs. 11.0%; p < .0001). These factors may have contributed to the 
increased likelihood of medication treatment. Physical disability is a measurement that was not 
studied in previous research but may be important in understanding the use of psychotropic 
medication and should be included in future studies.  
One finding that differed from other studies was that living in rural areas decreased the 
likelihood of medication use whereas prior studies found no significant association. The lower 
likelihood of psychotropic medication use for children in rural counties may be due to a lack of 
mental health specialists in rural counties. Future studies should examine the role of the 
availability of mental health specialists on psychotropic medication use and determine.  
The differences in abuse history of medication use may be a result of differences in the 
manifestations of the traumatic experience and subsequent treatment modality. Although 
children who experienced sexual abuse had the highest rates of medication, similar to what was 
found in prior studies, for those that were medicated, experiences of physical abuse were more 
predictive of psychotropic medication use. This study found a negative association of medication 
for children who experienced neglect and other forms of abuse that was found to have no 
association in earlier studies (Raghavan et al., 2012; Raghavan et al., 2014a; Raghavan et al., 
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2014b). This difference may be due to different data sources for abuse history: studies that found 
no association between sexual abuse and neglect used the National Survey of Child and 
Adolescent Well-Being (NSCAW). Variations in abuse history on medication use may vary by 
state and more studies from different data sources are needed to make generalizations. In the 
overall population, sexually abused children had the highest levels of medication use, especially 
with antidepressants, antipsychotics, and stimulants. A large, multicenter study on treatment 
responses in chronic depression found that for children with a history of early childhood trauma, 
psychotherapy alone was superior to antidepressant monotherapy and combination of 
psychotherapy and pharmacotherapy was only marginally superior to psychotherapy alone 
(Nemeroff, et al., 2003). This study highlights the importance of psychotherapy especially 
among the childhood abuse cohort. 
Like previous findings, children under the age of 5 years had the lowest probability of 
receiving psychotropic medication. This may be because natural developmental constraints may 
make identifying the need for mental health services more difficult. In addition, the use of 
psychotropic medication among this very young population has been highlighted as an area for 
increased concern and scrutiny due to concerns about the safety of medication use at such a 
young age when rapid brain development occurs as well as the potential long-term risks 
associated with the metabolic side effects (Andrade et al, 2011; Correll, 2008; Correll et al., 
2009; Debar, Lynch, Powell, & Gale, 2003; dosReis et al., 2014; Fontanella, Hiance, Phillips, 
Bridge, & Campo, 2014; Maayan & Correll, 2011). Few mental health specialists may be willing 
to accept children of such young ages (Bennet et al., 2013; McWillian, Young, & Harville, 
1996). As a result, there are very few cases of children under five years receiving medication.  
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However, this low medication rate does not necessarily mean there is no need for services 
at this age group. In fact, there is evidence that even very young children in the child welfare 
system are particularly vulnerable to emotional and behavioral problems. Research suggests that 
12% to 16% of 1- and 2-year-old children living with known environmental risk factors such as 
poverty, substance abuse, domestic abuse, and abuse and neglect demonstrate a significant delay 
in social-emotional competence and 37% of them continue to exhibit problem behaviors into 
their preschool years (Briggs-Gowen, Carter, & Skuban, 2001). Another evaluation of a state 
with universal preschool services noted that on average, there are three disruptive children per 
classroom (Henry, Gordon, Mashburn, and Ponder, 2001). Interventions for early psychosis in 
very young children should involve models of family support; however, these types of family 
interventions have been adopted slowly and may not be keeping pace with demand (Selick et al., 
2017).  
As children on medication are more likely to be older, it is especially important that 
processes of consent and assent are in place. Informed consent is a process in which doctors or 
specialists provide information regarding possible treatment options for making health decisions. 
Children in foster care are particularly vulnerable of lacking a voice in their mental health 
treatment due to their age and because they are estranged from natural, biological parents who 
traditionally oversee and consent to mental health decisions. In a study of six state programs, 
only one state fully implemented procedures that were consistent with the American Academy of 
Child and Adolescent Psychiatry’s (AACAP) best practice guidelines for consent procedures 
(Congressional Research Service, 2017). Special consideration may be required for how laws 
and policies establish consent and assent. 
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When observing the main effects of placement, the use of medication was greatest among 
children placed in out-of-home care although children placed in kinship care had the lowest 
probability of receiving medication which may give support to theory that children who are 
separated from their natural kin have weakened social bonds that may serve as a protective factor 
against over-medication (Longhofer, Floersch, & Okpych, 2010; Naylor et al., 2007; Scozzaro & 
Janikwoski, 2015). There was a particularly strong growth in psychotropic medication use 
among children placed in therapeutic foster care. A study on youth admitted to a therapeutic 
family home program found that many of the youth admitted were on psychotropic medications 
that were not needed, and the medications could safely and successfully be removed in the 
context of a strong psychosocial treatment milieu (Handwerk, Smith, Thompson, Spellman, & 
Daly, 2008). Conversely, children in group homes experienced a decrease in the use of 
psychotropic medication. This may be because children who enter into large residential group-
home facilities receive intensive services which may stabilize their behavioral or emotional 
problems and result in less medication. Studies of children admitted to a group home found a 
significant reduction in the utilization of psychotropic medication from admission to departure 
(Connor & McLaughlin, 2006; Handwerk et al., 2008). Although determining whether a 
reduction in medication is the appropriate treatment strategy cannot be discerned from these data, 
children departing the group homes without medication were rated as more improved, meeting 
more treatment goals, and more likely to succeed post-placement (Handwerk et al., 2008). This 
finding may suggest children who leave without medication gained other social or 
cognitive/behavioral skills, allowing them to forego reliance on medication and ultimately, 
having better proximal outcomes. The effect of placement on medication use differed 
significantly by reported diagnosis. For each placement type, those with either severe psychotic 
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disorder or non-severe psychotic disorder had higher likelihood of medication than those without 
a mental health disorder. 
Nearly all children who were medicated also had a mental health diagnosis; the 
proportion of children with a diagnosis also grew over time. The prevalence in having a mental 
health diagnosis with medication is in-line with best-practice recommendations (American 
Academy of Pediatrics, 2011; Costle, Aubert, Verbrugge, Khalid & Epstein, 2007). However, 
even at the peak of diagnosis, about 2% did not have a diagnosis. The lack of a diagnosis may be 
due to physicians not documenting the presence of mental health disorders which would results 
in an undercount of diagnoses. All physicians and psychiatrists should be encouraged to 
document mental health diagnoses of their clients to promote a thorough and transparent mental 
health treatment plan, particularly among the child welfare population who are prone to change 
placements and providers multiple times. 
Disruptive disorder was the most prevalent diagnosis among those that were medicated 
which also grew during the study period. Research shows that maladaptive parenting is strongly 
correlated with disruptive behavior among youth, the growth in disruptive disorder may have 
been due to historical underreporting of the diagnosis (Hoge, Guerra, & Boxer, 2008). The 
prevalence of this disorder may support the argument that behavior management rather than 
reducing symptoms of mental disorders are motivating caretakers to pursue psychotropic 
medication treatment (Arango, Parellada, & Moreno, 2004; Longhofer, Floersch, & Okpych, 
2010). Whatever the reason, disruptive disorders such as oppositional defiant disorder and 
conduct disorder put children at high risk of impairment and dysfunction; many develop 
antisocial personality or other personality disorders later in life, have significantly increased risk 
of violent and nonviolent delinquency in adolescents, and cost more in public services through 
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adulthood (Broidy et al., 2003; Scott, Knapp, Henderson & Maughan, 2001; Zoccolillo, Pickles, 
Quinton, & Rutter, 1992). Therefore, more investments may be needed to address disruptive 
disorders in foster care; a systematic literature review of evidence-based psychosocial treatments 
for the treatment of disruptive disorder found that effective treatment addresses not only the 
youths’ cognitive impairments but also risk factors in their social ecology such as family 
dynamics, deviant peer associations, and school (McCart & Sheidow, 2016). 
ADHD was the second most diagnosed mental illness in this study. A study that 
examined a large sample of children in a child welfare population who underwent a 
comprehensive diagnosis found that many children who were diagnosed with ADHD were 
misdiagnosed and actually suffered from fetal alcohol spectrum disorder (Chasnoff, Wells, & 
King, 2015). A misdiagnosis of ADHD often leads to inappropriate medication use. A future 
study is warranted to determine the accuracy of ADHD diagnosis for children in child welfare. 
Most of the children who were medicated received drugs from more than one class of 
psychotropic medication at a time—up to six different classes at once. The most common form 
of polypharmacy was the combination of antidepressants and stimulants. Clinicians often 
combine one or more psychotropic classes with stimulants to treat comorbidity such as 
aggressive outbursts associated with disorders of conduct or mood (Safer et al., 2003), 
augmenting partial response to stimulants (Greenhill et al., 2002), reversal of stimulant-induced 
insomnia (Prince, Wilens, Biederman, Spencer, & Wozniak, 1996), and/or accelerating response 
to antidepressants (Lavretsky, Kim, Kumar, & Reynolds, 2003).  A literature review on treatment 
of children with ADHD with comorbid anxiety or depression revealed no controlled studies that 
supports the efficacy of combining stimulants and antidepressants (Bhatara, Feil, Hoagwood, 
Vitiello, & Zima, 2002). Stimulants, antidepressants, and antipsychotic medications were often 
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the most commonly prescribed medications no matter the diagnosis. Polypharmacy is a concern 
because the frequency of adverse drug reactions may increase with the number of concomitant 
medications (Bhatara, Kallepalli, Misra, & Awadallah, 1996; Bhatara, Magnus, Paul, & 
Preskorn, 1998). Furthermore, children may be more vulnerable to adverse effects associated 
with multiple medications because of their immature organ systems (Woolston, 1999). The 
practice of prescribing two or more classes of psychotropic medication requires additional 
caution and monitoring of the child’s health (Correll, Rummel-Kluge, Corves, Kane, & Leucht, 
2009; Glick, Phan, & Davis, 2006; Maayan & Correll, 2011; Megna et al., 2007). 
The use of stimulants seems to have become a widespread practice for children in foster 
care, with more than three out of four children who are medicated receiving a prescription for 
that class of medications. The high rate of stimulants is consistent with clinical guidelines; 
stimulants are the first line of treatment for older children who have had a thorough assessment 
and been diagnosed with ADHD, as it is the cornerstone in symptom relief necessary for other 
treatments to be effective (American Academy of Pediatrics, 2011). However, there are concerns 
with the use of antidepressants due to concerns related to antidepressant-associated suicidality 
(Valluri et al., 2010). In addition, most children receiving antipsychotic medications receive 
them for non-approved psychiatric conditions (Pathak, West, Martin, Helm, & Henderson, 2010; 
Zito et al., 2008). Further longitudinal studies may be helpful in examining what, if any, 
supplemental treatment is provided and whether children received specialty mental health care. 
Limitations and Strengths 
One of the greatest benefits of using administrative datasets is the large number of 
observations with data entered in real-time by administrators, allowing for more complex 
statistical analysis. Because the use of administrative datasets allows for an entire universe of 
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population, selection bias is also not a concern. However, a common limitation when working 
with administrative data for research purposes is that the researcher is limited to the variables 
collected for administrative purposes and not necessarily towards research aims. For this study, 
diagnostic coding provided through the Medicaid administrative dataset may not accurately 
reflect the clinical purposes for prescribing the psychotropic medication. Mental health variables 
such as clinical assessment of behavior or emotional disturbances or trauma history that specifies 
type and severity would have been beneficial for analysis. Financial incentives may influence 
how physicians bill Medicaid for the services provided. Also, child need was collected only 
through diagnosis and abuse history which are somewhat crude measures of mental health need.  
This study area and population is innately complex with children in multiple placements, 
having multiple diagnoses, and receiving multiple medications. For example, children often had 
more than one diagnosis and/or medication which complicated analysis and interpretation of the 
results. Although measures to reduce the overlap of diagnoses were taken by applying a 
hierarchical approach, in practice, children often had multiple diagnoses at a time. In addition, a 
child was grouped into the medication group if they received a psychotropic medication at any 
point during their spell which is a crude construction of medication group. Future studies may 
consider other measures to capture degrees of medication such as creating low, medium, and 
high medication use groups. 
This paper provided a descriptive analysis characterizing children in foster care and the 
prescription of psychotropic medication in this population. It also examined characteristics that 
were associated with medication use. However, there are other proximal outcomes that will be 
examined in Paper III such as the effects of medication use on foster care experiences such as 
length of time in care, number of placements, and exit types. Based on the findings of this paper, 
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children diagnosed with severe psychotic disorders such as schizophrenia, pervasive 
developmental disorder, or bipolar disorder and very young children under the age of five appear 
to be a special population that warrants separate analysis. 
Conclusions 
 The findings of this paper confirm many of the findings of previous research while 
raising additional concerns. The rate of medication use for children in the North Carolina foster 
care system with the national range of medication rates found in prior studies, based on the 
systematic literature review and meta-analysis from Paper I. Medicated children in the North 
Carolina foster care system also shared many of the characteristics of children in other foster 
care systems in the United States such as demographic characteristics that elevate a child’s 
likelihood of receiving psychotropic medication (e.g., being male, White, older, and experiences 
of physical abuse). Receiving a mental health diagnosis was highly predictive of medication use 
and the predictive quality increased with severity of the mental illness. Children diagnosed with 
schizophrenia, pervasive developmental disorder, and bipolar disorder may be a special sub-
population in further analysis. Furthermore, very young children may also be another 
subpopulation whose experiences may not be generalized with those older children.  
This study confirms the findings of previous studies that children in out-of-home 
placements are more likely to receive psychotropic medication than those in in-home settings. 
Precaution is reasonable for this vulnerable population because they are estranged from their 
natural, biological social ties that are a common sources of oversight and consent in mental 
health treatment decisions. Disruptive disorder was the most common diagnosis and increased 
over time. More resources should be targeted to this subpopulation of foster youth through a 
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psychosocial and ecological framework as medication only targets the symptoms and children 
will need cognitive and social skills to improve social functioning and quality of life. 
This paper adds to the body of work to better understand the use of psychotropic 
medication for children in foster care. This research is also the first to comprehensively examine 
children in the North Carolina foster care system and the characteristics of those who are 
medicated. The large study sample that spans several years enables not only the detailed analysis 
found in this current paper but will also be beneficial for future statistically intensive analysis. 
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APPENDIX B: PLACEMENT BY DIAGNOSIS INTERACTION MODEL 
 
Model 1 
β 
Model 2 
β 
Time 0.01*** 0.01*** 
Individual-level factors   
Gender   
Male (Ref. Female) 0.43*** 0.43*** 
Race   
Black (Ref. White) -0.38*** -0.38*** 
Hispanic (Ref. White) -0.52*** -0.52*** 
Other (ref. White) -0.08*** -0.08*** 
Age in years   
 0-4 (ref. 15-19) -1.82*** -1.82*** 
 5-9 (ref. 15-19) 0.18*** 0.18*** 
 10-14 (ref. 15-19) 0.28*** 0.28*** 
    Physical disability 0.99*** 0.97*** 
    Parental substance abuse -0.10*** -0.10*** 
    Single parent -0.07*** -0.70*** 
Abuse history   
 Physical abuse 0.11*** 0.11*** 
 Sexual abuse -0.02 -0.01 
 Neglect -0.25*** -0.26*** 
 Other -0.25*** -0.26*** 
Placement type   
 Foster home (ref. Other) 0.18*** -0.32*** 
 Therapeutic foster home (ref. Other) 1.19*** 0.31** 
 Residential group home (ref. Other) 1.14*** 0.86*** 
 Kinship care (ref. Other) -0.08*** -0.57*** 
Mental health diagnosis   
Severe psychotic disorder (ref. None) 4.44*** 4.06*** 
Non-severe psychotic disorder (ref. None) 3.28*** 2.82*** 
Entry cohort -0.12*** -0.12*** 
County-level factors   
Rurality   
Metropolitan (ref. Rural) 0.20 0.20* 
Placement x Major Diagnosis interaction   
          Foster home x Severe psychotic disorder  0.55*** 
          Foster home x Non-severe psychotic disorder  0.53*** 
          Foster home x No mental health disorder  - 
          Therapeutic foster home x Severe psychotic disorder  0.48*** 
          Therapeutic foster home x Non-severe psychotic disorder  1.00*** 
          Therapeutic foster home x No mental health disorder  - 
          Residential group home x Severe psychotic disorder  0.44*** 
          Residential group home x Non-severe psychotic disorder  0.25** 
          Residential group home x No mental health disorder  - 
          Kinship care x Severe psychotic disorder  0.54*** 
          Kinship care x Non-severe psychotic disorder  0.51*** 
          Kinship care x No mental health disorder  - 
          Other x Severe psychotic disorder  - 
          Other x Non-severe psychotic disorder  - 
          Other x No mental health disorder  - 
* p < .05, ** p < .01, *** p < .001   
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PAPER III 
 
EFFECTS OF MEDICATION ON FOSTER CARE OUTCOMES 
 
Abstract 
 This study used administrative data to examine the effect of psychotropic medication use 
on three foster care outcomes – time to exit, exit type, and placement stability. Stabilized 
inversed probability of the treated weights were used to make causal inferences using secondary 
data analysis. First, Cox regression modeling was used to analyze differences in time to exit by 
status. Second, Poisson count regression was used to analyze the hazard rate of experiencing a 
placement disruption experienced by medication status. Lastly, a multinomial regression was 
used to analyze difference in exit types (adoption, guardianship, reunification or others) by 
medication status. Results revealed that children on medication had more stable placements but 
stayed in care longer and less likely to exit to permanency. Implications of these findings for 
child welfare research and practice are discussed. 
Keywords: Foster care; Psychotropic medication; Permanency; Placement stability; IPTW 
  
95 
Introduction 
 The use of psychotropic medication among children in foster care has been a topic of 
national concern for nearly a decade (Government Accountability Office, 2006). Studies have 
confirmed anecdotal evidence that children in foster care are medicated at high rates (dosReis et 
al., 2011; Zito et al., 2008; Zito, Burcu, Ibe, Safer & Magder, 2013). In North Carolina, over half 
of the children in foster care between March 2006 and June 2012 had received psychotropic 
medication at least once during their time in care (Paper II). Despite these high rates of 
medication use, the body of literature in this area has mainly been limited to descriptive analysis. 
This paper begins to address questions on the effect of medication use on foster care experiences 
such as length of time in care, placement stability, and exit to permanency. 
Few studies have been able examine the causal effects of medication use on the 
experiences of children in foster care. Although a randomized controlled trial is considered the 
gold standard for evaluating the effect of a treatment because it minimizes bias, experimental 
studies on the use of medication are prohibited for ethical reasons including the highly 
vulnerable status of children in foster care; therefore, research conducted in this area has been 
limited to the use of secondary, administrative data. However, in the absence of randomization, 
findings may be misleading due to confounding. In other words, differences in observed and 
unobserved characteristics between the treatment groups may influence outcomes, meaning that 
causal inferences cannot be made. 
Modern statistical techniques can help overcome many of these obstacles. Without 
statistical controls, outcome measures are highly confounded with the use of medication. 
Propensity scoring is one statistical method that helps address the challenge of selection bias 
(i.e., confounding bias) inherent in secondary data. Using propensity scores reduces bias from 
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observational data by adjusting for group differences using a conditional probability of being 
treated based on individual covariates (Rosenbaum & Rubin, 1983). An individual’s propensity 
score is his or her probability of having received a treatment (e.g., psychotropic medication), 
conditional on a host of confounding variables. The propensity score is then used to adjust for 
confounding in subsequent analysis, which allows for more plausible causal inferences to be 
drawn.  
This paper utilizes rigorous observational designs (i.e., propensity score analysis) to 
reduce confounding due to imbalanced distributions of measured baseline covariates in effort to 
help make causal inferences about the effects of medication use on children’s experiences in 
foster care.  
Literature Review 
Since the passage of the Adoption and Safe Families Act of 1997, the U.S. Department of 
Health and Human Services has established several important objectives and outcomes of 
interest that relate to the safety and well-being of children in foster care. Three of those outcomes 
are investigated in this paper: reducing time in foster care, achieving permanency for children in 
foster care, and increasing placement stability. 
Correlates of Foster Care Length of Stay 
Several studies have been conducted that examined child, familial, and placement 
characteristics associated with time in foster care. In a comprehensive study of children who 
were in care for more than three years, minority status, disability, sexual abuse history, 
externalizing behavior problems (e.g., attention deficit hyperactivity disorder or ADHD), and 
parental substance abuse were associated with increased time in foster care (Glisson, Bailey, & 
Post, 2000). Other studies have also supported the finding that minorities were more likely to 
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stay in care longer than Caucasian children (Barth, 1997; Becker et al., 2002; Davis, Landsverk, 
& Newton, 1997; Wells & Guo, 1999). Another study found that children with developmental 
disabilities or other health problems and children of parents with substance abuse problems were 
in foster care significantly longer than other children (Benedict & White, 1991). Age was also a 
correlate of length of stay: several studies found an inverse relationship between the child’s age 
at the time of placement and time in foster care (Barth 1997; Rushton & Dance, 2003; Simmel, 
Brooks, Barth & Hinshaw, 2001).  
Correlates of Exits to Permanency 
One of the main goals of the child welfare agency once a child enters foster care is to find 
a safe, permanent home for them as quickly as possible. This is objective is a concept known as 
“permanency.” Reunification, which is when children transitions back to their family, is the 
preferred outcome for a child that is removed from their homes and placed in foster care (Child 
Welfare Information Gateway, 2013). However, when reunification is not feasible, children may 
find permanent homes with relatives or other families through legal guardianship or adoption. 
Child characteristics associated with exits to permanency have been investigated, with varying 
degrees of uniformity in conclusions. Previous studies on exit type have found that age was 
related to the type of exit the child experienced: infants were more likely to be adopted while 
older children were more likely to be reunified, leave for legal guardianship, or exit to a relative 
custodian (Akin, 2011; Barth, 1997; Connell, Katz, Saunders, & Tebes, 2006; Courtney & 
Wong, 1996; Snowden, Leon & Sieracki, 2008; Winokur, Holtan, & Valentine, 2009; Wulczyn, 
2003). African Americans were less likely to be reunified or adopted (Akin, 2011; Barth, 1997; 
Connell et al., 2006; Courtney & Wong, 1996; Snowden et al., 2008; Wulczyn, 2003). Latinos 
98 
were also less likely to be adopted (Courtney & Wong, 1996; Snowden et al., 2008; Wulczyn, 
2003).  
Most studies did not find an association between exit to permanency and gender (Barth, 
1997; Becker et al., 2007; Benedict & White, 1991; Connell et al., 2006; Courtney, 1994; 
Courtney et al., 1997; Courtney & Wong, 1996; Davis et al., 1996; Glisson et al., 2000; 
Landsverk et al., 1996; Leathers, 2005; McMurtry & Lie, 1992; Pabustan-Claar, 2007; Park & 
Ryan, 2009; Potter & Klein-Rothschild, 2002; Romney et al., 2005; Rosenberg & Robinson, 
2004; Wells & Guo, 1999; Yampolskaya et al., 2007) although there were a few exceptions that 
found that girls were more likely to achieve permanency than boys (Harris & Courtney, 2003; 
Kemp & Bodonyi, 2000; Snowden et al., 2008; Vogel, 1999).  
Health problems are believed to lower the likelihood to adoption or reunification because 
such problems are less desirable for potential adoptive families (Meezan, Katz, & Ross, 1978) 
and the stresses associated with caring for such children may reduce the likelihood of 
reunification or guardianship. In literature, though, the evidence for the negative effect of a 
child’s health on exit to permanency was inconsistent: While some studies did find a negative 
association of a child’s health status with reunification and adoption (Connell et al., 2006; 
Courtney & Wong, 1996), others found that children with health problems were more likely to 
be adopted (Akin, 2011; Snowden et al., 2008). Findings regarding a child’s health are difficult 
to generalize because of inconsistent definitions of health: for example, some studies used a 
disability status (e.g., mental retardation, visual or hearing impairment, or a physical disability) 
as a measurement for health while others reported health problems as identified by a social 
worker which may include physical, emotion, and/or mental disabilities.  
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Studies that examined the association of parental factors with permanency outcomes 
found that children of parents with substance abuse issues were less likely to reunify or be 
adopted (McDonald, Poertner, & Jennings, 2007; Rosenberg & Robinson, 2004; Snowden et al., 
2008). Family poverty, which was identified through welfare eligibility, was also linked with 
lower rates of reunification or adoption (Courtney, 1997; Courtney & Wong, 1996). Findings on 
studies that examined single parent family structures varied: most found lower rates of 
reunification (Courtney, 1994; Courtney et al., 1994; Davis et al., 1996; Harris & Courtney, 
2003; Landsverk et al., 1996; McDonald et al., 2007; Wells & Guo, 1999) whereas one study did 
not find significant association between family structure and reunification (Courtney & Wong, 
1996). There were even studies regarding the association of environmental factors with exit type: 
some studies have found that foster children living in urban areas were less likely to be adopted 
(Courtney & Wong, 1995; Wulczyn, 2003). 
Several studies examined the association between various placement characteristics with 
exit types. For example, physical maltreatment and sexual abuse were associated with higher 
rates of reunification (Akin, 2011; Courtney, 1994; Courtney & Wong, 1995; Davis et al., 1996). 
Sexual abuse was associated with lower rates of adoption (Connell et al., 2006; McDonald et al., 
2007). There were conflicting findings on the relationship between neglect and reunification: 
some studies found that neglect increased reunification rates (Courtney & Wong, 1996; Harris & 
Courtney, 2003) while others found that it decreased reunification rates (Connell et al., 2006; 
Wells & Guo, 1999). These differences may be due to differences in states that were the source 
of data for the studies. Another study found that children who experienced neglect had higher 
rates of adoption (Connell et al., 2006). Children placed with relatives had lower rates of 
reunification and adoption (Connell et al., 2006; Courtney & Wong, 1996; Winokur et al., 2009; 
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Wulczyn, 2003). Also, when the child’s initial placement was a group home or emergency 
shelter setting, the child was less likely to reunify with their parents or be adopted (Connell et al., 
2006; Courtney & Wong, 1996; Park & Ryan, 2009). The relationship of a child’s placement 
stability exit to permanency is also unclear: some studies have found no significant relationship 
with any permanent exit types (Park & Ryan, 2009; Potter & Klein-Rothschild, 2002) while 
others have found that the number of placement settings was inversely associated with lower 
rates of reunification and adoption (Goerge, 1990; Smith, 2003).  
Correlates of Placement Stability  
The literature on predictors of placement disruptions found that the child’s age, emotional 
and behavioral problems, number of prior placements, number of children placed in the home, 
and poor parent-child relationship or child’s inability to form positive attachment to the adult 
caretaker were positively related to placement disruptions (Akin, 2011; Chamberlain et al., 2006; 
Connell et al., 2006; Moore, Osgood, Larzelere, & Chamberlain, 1984; Smith et al., 2001; Stone 
& Stone, 1983; Testa, Nieto, & Fuller, 2007; Zinn et al., 2006). On the other hand, kinship 
placement, sibling placement, positive relationships with foster and biological families, and 
positive relationship with the caseworker and/or agency were associated with increased 
placement stability (Akin, 2011; Chamberlain et al., 2006; Connell et al., 2006; Holland et al., 
2005; Hurlburt et al., 2010; James, 2004; James et al., 2004; Pardeck, 1984; Stone & Stone, 
1983; Webster et al., 2000; Wulczyn et al., 2003). The literature had mixed results on the 
association between race and placement stability: one study found that Caucasians were more 
likely to disrupt (Webster, Barth, & Needell, 2000), another study found that Latinos were more 
likely to disrupt (Farmer, Mustillo, Burns, & Holden, 2008), and others found no effect of race at 
all (Connell et al., 2006; James, 2004; Orme et al., 2006). The relationship between gender and 
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placement stability was also unclear: one study found that boys were less stable (Palmer, 1996), 
others found that boys were more stable (Stith et al., 2009; Webster et al., 2000) whereas others 
found no effect of gender on placement stability (James, Landsverk & Slymen, 2004; Wulczyn, 
Kogan & Harden, 2003).  
Gaps in the Literature 
Previous research on the use of psychotropic medication for children in foster care has 
mostly been limited to descriptive analysis due in part to data and statistical limitations. Studies 
conducted on the use of psychotropic medication among children in foster care have been limited 
to descriptive, bivariate/multivariate analysis. One study (Tai, Shaw, & dosReis, 2016) studied 
the effect of psychotropic medication use on placement stability but this study was focused 
exclusively on antipsychotic medication use and children with ADHD/Disruptive Behavior 
Disorders. In order to make the kind of causal inferences that traditional, randomized control 
trials can make, researchers must first address inherent limitations such as confounding variables 
encountered when conducting outcome studies using administrative data. To address the problem 
of confounding with the use of secondary data, a statistical control such as propensity score 
weighting is needed.  
Although most studies on the use of psychotropic medication with children in the child 
welfare system have been cross-sectional in nature, a few studies were analyzed longitudinally 
and with propensity score analysis to address selection bias (Akin, 2011; Raghavan et al., 2012; 
Raghavan et al., 2014; Tai, Shaw, & dosReis, 2016), none of these studies have used propensity 
scoring with time-varying covariates. A subset of propensity score weighting, the Inverse 
probability of treatment weighting (IPTW), is a statistical technique that is gaining in popularity 
in the biomedical field to address selection bias in longitudinal data analysis with time-varying 
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covariates (Austin & Stuart, 2015). With large datasets available through administrative data 
sources and the advancements of statistical techniques, the information from time-varying 
covariates should be included in longitudinal analysis while also controlling for selection bias 
through IPTW.  
This study used the knowledge established by prior studies regarding the correlates of 
foster children’s length of stay, placement stability, and permanency and examined causal effects 
of the use of psychotropic medication on a foster child’s experiences. IPTW was used to conduct 
three separate analysis to test differences in length of foster care placement, placement stability, 
and exit type between children who receive psychotropic medication and those who are not 
medicated. 
Propensity Score Weighting 
Although experimental methods are ideal for making causal inferences, randomization is 
not always feasible. This is the case with foster children and medication use; therefore, 
alternative statistical controls such as propensity score methods are needed. To take advantage of 
statistical controls, large datasets are required. Administrative and Medicaid claims data are a 
rich source of information and a useful way of ethically exploring the effects of psychotropic 
medication on foster children. 
Propensity scoring is an effective method to control for covariates and extraneous factors 
that threaten internal validity (Guo & Fraser, 2010). The propensity score (ei) is a conditional 
probability of being assigned (or selected) to a treatment group such as receiving psychotropic 
medication (Z=1 vs. Z=0), conditional on observed baseline covariates (X). The propensity score 
is formally expressed as 𝑒𝑖 = Pr(𝑍𝑖 = 1|𝐗𝑖). The baseline covariates should contain all 
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confounders; this is known as the condition of ignorability or the assumption of no unmeasured 
confounders (Rosenbaum & Rubin, 1983).  
There are several methods of applying propensity scores to estimate causal effects in 
observational studies such as propensity score matching (PSM), inverse probability of treatment 
weighting (IPTW), stratification on the propensity score and covariate adjustment using 
propensity scores. IPTW has not been used widely in social work research but is more frequently 
seen in epidemiological research. A series of Monte Carlo studies found that PSM and IPTW 
using the propensity score provided better balance on baseline covariates compared to 
stratification on the propensity score and covariate adjustment using the propensity score 
(Austin, 2009). Austin (2013) recommended that for estimating the effects of treatment on 
survival outcomes, researchers should use either PSM or IPTW. In this dataset, the untreated 
group (i.e., non-medicated sample) is not substantially larger than the treatment group (i.e., 
medicated sample) which is required for pair matching (Austin, 2014). Therefore, IPTW is the 
most appropriate for this dataset and subsequent analysis.  
IPTW uses weights based on the propensity score to adjust the sample distribution of 
measured baseline covariates so that it is independent of treatment assignment. In effect, 
balanced covariates can no longer be confounders. IPTW was first proposed by Rosenbaum 
(1987) as a form of model-based direct standardization and belongs to a larger class of models 
called marginal structural models that allows the user to account for time-varying confounders 
when estimating the effect of time-varying exposures (Robins, Hernan, & Brumback, 2000). As 
such, IPTW is particularly attractive for use with longitudinal data. IPTW allows for the 
estimation of marginal hazard ratios which can then be used to quantify the relative reduction in 
the hazard of an event occurring in a treated population compared with an untreated population. 
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For complex study designs and research questions, IPTW is the preferred method for analysis 
(Austin, 2013). 
Method 
Sample and Data Sources 
This study utilized linked North Carolina child welfare administrative records which had 
been linked with the North Carolina Medicaid claims database. All children who entered foster 
care in North Carolina between March 1, 2006 and June 30, 2012 were included. Preliminary 
analysis found extreme homogeneity in medication for children with severe, psychotic mental 
illnesses that would prohibit meaningful analysis. Therefore, children diagnosed with 
schizophrenia, pervasive developmental disorder/mental retardation, and bipolar disorder were 
excluded from the sample. In addition, there were too few medicated children under the age of 
five years and so children who entered care before the age of five was also eliminated. The data 
were restricted to a child’s first spell, a common practice in child welfare research. A spell is 
defined as a continuous period of time a child is placed in state custody beginning with when the 
child is taken into the custody of the state and continues until the child is discharged from the 
foster care system by way of exiting the system (e.g., reunification, adoption, aging out at the age 
of 18). Children who exit the child welfare system and re-enter at another date are a small and 
atypical sub-population which would require separate analysis. The federal Adoption and Foster 
Care Analysis and Reporting System (AFCARS) data reported a median state re-entry rate of 
11.8% in 2012 (U.S. Department of Health and Human Services Administration for Children and 
Families, 2014). If there was a gap of less than 7 days between the end of the first placement 
authority and the beginning of the subsequent placement authority, the gap is “bridged” and the 
two separate spells are treated as one single spell as the change may be result of “paper changes” 
105 
that could be a reflection of idiosyncratic reporting practices (Wulczyn, Barth, Yuan, Harden, & 
Landsverk, 2017).  
Information on the child’s foster care experiences such as reason for entry, placement 
types, placement changes, and exit types were extracted from foster care administrative data (i.e., 
the Services Information System [SIS] data file). Information on medication and diagnosis was 
provided by the Medicaid claims data (i.e., Eligibility Information Systems [EIS]) which is 
managed by the Division of Medical Assistance operated under the Department of Health and 
Human Services (DHHS).  
The sample was divided into one of two treatment groups: those who received a 
psychotropic medication (i.e., antidepressant, antipsychotic, mood stabilizer, anxiolytic, 
stimulant, or alpha-adrenergic agonist [AAA]) during their time in foster care, and those who did 
not. 
Outcome Variables 
Length of time in care. Length of time in care was calculated as the number of months a 
child was in care starting from the month of the child’s placement authority beginning date to the 
month of the child’s placement authority ending date of his or her first spell. Although the 
original data had continuous collection of data (i.e., the unit of time was in days), this time 
format was too restrictive for data matching as well as computationally prohibitive in subsequent 
analysis. Therefore, the data were consolidated so that the month would be the smallest unit of 
time. To account for possible correlation in episode outcomes due to sibling groups removed 
within the same episode, a variance corrected approach was utilized by adjusting the standard 
error through a “robust standard error” estimation procedure.  
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Placement stability. The number of countable placement changes was used as a measure 
of placement stability. Placements that did not count towards a placement change included living 
with parents, children’s camp, hospital, independent living, maternity home, jail/detention, trial 
home visit, runaway, and respite care.  
Exit type. Exit type was categorized as either reunification, adoption, emancipation, or 
other. The reason for leaving care was provided in the administrative dataset. Exit types that are 
considered permanent exits as defined by the Children’s Bureau of the U.S. Department of 
Health and Human Services are reunification, adoption, and guardianship. When children exit for 
“other” reasons (i.e. transfer to another agency, runaway, death, interstate compact placement 
terminated, authority revoked for reasons other than above, and other), a permanent exit type was 
not achieved.  
Independent Variables 
Child characteristics. Sociodemographic characteristics such as gender (male or female) 
and race (White, Black, or Other) were collected from foster care administrative records. Age 
was calculated for the day the child entered care and for each month he/she were in care using 
the date of birth provided by the administrative records. Children with a physical disability was 
identified as such by their foster care records. Foster care administrative records also identified if 
a child’s parent had a substance abuse problem and information on the family structure was used 
to create a binary variable was created to identify children who had a single parent. 
Episode characteristics. The reason for the child’s removal from the home provided 
information on the child’s abuse history. There were four binary variables used to describe abuse 
history: physical abuse, sexual abuse, neglect, and other. The “other” category included parent 
alcoholism, abandonment, child behavior, coping, parent death, parent drug abuse, child drug 
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use, incarceration, child disability, and inadequate housing. A child may have had one or more 
reasons for removal.  
Placement type described the child’s living arrangement and was captured by five binary 
variables: foster home, therapeutic foster home, kinship care, group placement, and other. 
“Other” placements include children’s camps, emergency shelters, hospitals, independent living, 
jail/detention, legal guardian, maternity home, other court approved placement, unknown, 
parents, respite care, trial home visit, juvenile justice residential facility, and unknown/missing.  
Foster children often experienced changes in placements during their time in foster care. Since 
month was the smallest unit of time for the dataset, when there was more than one placement 
documented in a month, the placement that the child was in the longest was used for the child’s 
placement type for that month.  
Although the number of placements was one of the outcome variables of interest, because 
it was used as a variable to control when studying time to exit and exit type in prior studies, it 
was also used as an independent variable for the outcomes of time in care and exit type. Entry 
cohort was the calendar year the child entered foster care. 
Rurality. Whether the child lived in a rural or an urban county is often included in child 
welfare research to control for disparities in resources or culture. A variable indicating whether 
the county in which the child resided is metropolitan or not was created by using the 2013 Urban 
Influence Code assessment for the child’s county. These classifications (metropolitan vs. rural) 
were based on the size of the county’s largest city or town and its proximity to metro- and 
micropolitan areas (Economic Research Service, 2013).  
Medical information. Clinical information such as diagnosis and medication were 
collected from the Medicaid claims database. Mental health diagnosis was labeled according to 
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the Diagnostic and Statistical Manual of Mental Disorders IV-TR and coded using the 
International Classification of Diseases, Ninth Revision (ICD-9) classification. To prevent 
overlap of diagnostic categories, a hierarchical approach created by Olfson and others and 
expanded by Zito and colleagues was adopted beginning with schizophrenia and other psychoses 
and followed by pervasive developmental disorders and mental retardation (PDD/MR), bipolar 
disorder, disruptive disorders, attention-deficit hyperactivity disorder (ADHD), depressive 
disorders, anxiety disorders, adjustment disorder, communication or learning disorders, or any 
other psychiatric diagnosis (Olfson, Blanco, Liu, Moreno & Laje, 2006; Zito et al., 2013). 
Preliminary analysis demonstrated that the most severe psychotic disorders warrant a separate 
analysis as children with those diagnoses constituted an extremely unique group. Therefore, 
children diagnosed with schizophrenia, PDD/MR, or bipolar disorder were excluded from the 
sample. Also, due to extremely small cell sizes for children with communication disorders 
(<1%), children with communication disorders were placed into the “other” diagnosis group. 
 Psychotropic medication was classified according to the American Hospital Formulary 
Services (AHFS) pharmacologic therapeutic classification system. The six medication classes 
used in this study (i.e., antidepressants, antipsychotics, mood stabilizers, anxiolytics, stimulants, 
and alpha-adrenergic agonists [AAAs]) are the classes commonly used in similar studies. 
Data Analysis 
Since observational data were used for analysis, propensity score weighting was 
implemented to create weights that would adjust for confounding between treatment status and 
covariates. For complex data structures such as longitudinal data, IPTW is recommended as the 
preferred method over other propensity score methods such as matching, stratification, or 
adjustment (Austin, 2014). IPTWs were used with adjusted Cox proportional hazards model to 
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analyze length of time in care, negative binomial regression to analyze placement disruptions, 
and multinomial logistic regression to analyze permanency exit type. Most analyses were 
conducted using SAS, version 9.3 (SAS, 2011). The Poisson regression with IPTW weights was 
conducted using STATA, version 14.1 (StataCorp, 2016). A child’s placement setting, mental 
health diagnosis and medication prescribed may have changed from month to month. In order to 
account for the time-varying nature of these covariates in the analysis, the dataset was 
transformed using a counting method described by Allison (1995). 
Propensity score weighting. Propensity scores were used to remove the effects of 
confounding due to unequal distribution of measured baseline covariates (Rosenbaum & Rubin, 
1983). Logistic regression with a logit link was used to model the probability of receiving the 
treatment (i.e., psychotropic medication) as a function of possible confounders. Rosenbaum 
(2010) suggested using measures of constructs that were theoretically related to treatment 
selection; therefore, covariates to estimate the propensity score were included based on subject-
matter expertise and reviewing existing literature rather than on formal statistical hypothesis 
testing. In total, baseline values from 17 variables related to psychotropic medication use among 
children in foster care were chosen to estimate the propensity score. These variables captured 
gender, race, age of entry into foster care, placement type, abuse history, mental health diagnosis, 
entry cohort, and the rurality of the county in which the child was placed. The estimated 
propensity scores were then inverted to create IPTWs which were defined as 𝑤 𝑖 =
𝑍𝑖
𝑒𝑖
+
(1−𝑍𝑖)
1−𝑒𝑖
, 
where treated (Zi=1 if treated) is an indicator variable denoting whether the ith subject was 
treated and ei denotes the propensity score for the ith subject. 
Treated subjects with very low propensity scores or untreated subjects with high 
propensity scores produce large weights that can induce instability and cause estimation 
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problems. In order to reduce the influence of outlying weights, Cole and Hernan (2007) 
recommended the use of stabilized weights which were obtained by multiplying the IPTWs by 
the marginal probability of receiving the actual treatment received. Extreme weights were then 
truncated at the 5th and 95th percentile (i.e., scores less than the 5th percentile were set to the 
value of the 5th percentile and scores greater than the 95th percentile were set to the 95th 
percentile value; Lee, Lessler, & Stuart, 2011; Potter, 1993).   
After IPTWs were stabilized and truncated, the degree to which the estimates overlapped 
between treatment and control groups, also known as the region of common support, was 
assessed using visual comparisons of distributions of modeled probabilities stratified by 
medication status (Morgan & Todd, 2008). Boxplots and histograms were examined for 
overlapping propensity score distributions to demonstrate that there were individuals in the 
treatment group who had confounding variables similar to those in the control group. 
Distributions of propensity scores that do not overlap risk inaccurate conclusions due to unstable 
estimates of effects.  
Balance of the potential confounders was assessed using standardized mean differences 
to determine whether the differences between the baseline covariates of the treatment and control 
groups were successfully adjusted through IPTW. The differences in mean of each covariate is 
the differences in the proportions/means across the treatment groups divided by the standard 
deviation within the treatment group. 
?̅?𝑡 − ?̅?𝑐
𝜎𝑡
 
This measure, sometimes referred to as the standardized bias or standardized difference in 
means is preferable to significance testing for assessing balance because datasets with large 
sample sizes are more likely to find small differences statistically significant (Imai, King, & 
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Stuart, 2008; Rosenbaum & Rubin, 1985; Stuart, 2010). Recommendations differ as to the ideal 
cutoff value; for this study, Imben’s recommended cutoff value of < 0.25 was applied (Ho, Imai, 
King & Stuart, 2007; Normand et al., 2001).  
Time to permanency analysis. The study window closed before all the foster children 
exited care and therefore information on survival time was incomplete, a problem known as 
right-hand censoring. A foster child was also censored when the child exited care but not in a 
manner that is considered a permanent exit. These non-permanent exits may include runaways, 
aging out, and in very rare cases, death. Censoring could also occur when a child remained in 
care after the end of the study period. Survival analysis accounts for censoring which is 
necessary to avoid bias. Unlike ordinary regression models, survival methods appropriately 
incorporate information from both censored and uncensored observations. The Kaplan Meier 
method is a nonparametric estimator of survival function widely used to obtain univariate 
descriptive statistics for survival data such as median survival time and to test for overall 
differences between estimated survival curves of two or more groups of subjects through the use 
of log-rank test. Another popular survival method is the semiparametric Cox proportional 
hazards regression model that allows testing for differences in survival times of two or more 
groups of interest while allowing to adjust for covariates of interest.  
The effect of medication use versus non-medication on the hazard of exit to permanency 
was estimated from a multivariate, weighted Cox proportional hazards modeling to yield hazard 
ratios (HRs) and 95% confidence intervals (CIs) using the SAS procedure PROC PHREG. The 
hazard function describes the relative likelihood of an event occurring at time t and so the hazard 
rate describes the instantaneous rate of failure (i.e., exit from care) at time t. Stabilized IPTWs 
were used to address confounding and a “robust standard error” estimation procedure was used 
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to account for repeated measures from the same individual (Lin & Wei, 1989). Overall model fit 
was assessed using likelihood ratio chi-square test. 
Number of placement disruption analysis. A count regression model with IPTW was 
used to analyze the number of placement disruptions. Because a Poisson regression with 
complex data is not easily obtained in the available SAS programs, the STATA procedure 
POISSON with svyset for weighting with standardized IPTWs was used to perform the count 
analysis. Since some data were right-censored, exposure time was accounted by offsetting the 
log of the number of months in care. In so doing, the units of observation are different in some 
dimension and the outcome is proportional to that dimension: this results in modeling rates 
instead of counts. Robust standard error was also used to control for mild violation of the 
distribution assumption that the variance equals the mean (Cameron & Trivedi, 2009).  
Exit type analysis. A multinomial logistic regression with IPTW was used to analyze the 
different types of exits. The SAS procedure PROC SURVEYLOGISTIC was used to fit a 
generalized logit model using “Other” (i.e., a non-permanent exit) as the reference category. The 
likelihood ratio chi-square test was used to assess model fit. The Wald Chi-Square statistic and 
the corresponding p-values were used to test whether medication use (and other parameters) 
were significantly different from zero.  
Results 
After 14,529 children were excluded for entering care before the age of five, an 
additional 156 children were excluded for having a diagnosis of schizophrenia, 410 with a 
diagnosis of pervasive developmental disorder, and 783 with a diagnosis of bipolar disorder. The 
final sample included 14,779 foster children in the study of which 4,529 (30.6%) were medicated 
and 10,250 (69.4%) were not medicated during their time in foster care. The baseline variables 
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for the overall sample differed significantly for any diagnosis, disruptive disorder, and ADHD 
using the 0.25 mean difference threshold. The significant difference justified the use of IPTW to 
address the confounding variable.  
 Inverse Probability of the Treatment Weighted 
Common support assessment. The box plot showed that the propensity scores for the 
medicated group were on average, higher than those in the unmedicated group (see Figure 7). 
However, according to the visualization of the histogram, the large sample of unmedicated 
children allowed for some sufficient overlaps in propensity scores despite the differences in 
distribution (see Figure 8). 
 
Figure 7. Box plot showing overlap of logit propensity 
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Figure 8. Histograms showing propensity score distributions 
Balance assessment. Prior to propensity score weighting, there were possible 
confounding variables in the sample because the two treatment groups were not balanced in 
terms of children who were had any diagnosis or were diagnosed with disruptive disorder or 
ADHD (see Table 13). After adjustments were made using stabilized IPTW, only diagnosis of 
adjustment disorders exceeded the 0.25 threshold. Therefore, analysis using the estimated 
weights may be vulnerable to the confounding effects of adjustment disorders.  
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Table 13. Balance assessment of baseline characteristics between treated and untreated subjects 
(N=14,779) 
    Standardized Difference 
 
Unmedicated 
(n=10,250a) 
Medicated 
(n=4,529b) 
 Original 
Sample  
Weighted 
Sample 
Gender       
     Male (ref. Female) 4,670 (45.6%) 2,521 (55.7%)  0.20  0.04 
Race       
     White 4,765 (46.5%) 2,512 (55.5%)  0.18  0.02 
     Black 3,770 (36.8%) 1,451 (32.0%)  0.10  0.00 
     Hispanic 928 (9.1%) 251 (5.5%)  0.15  0.04 
     Other 787 (7.7%) 315 (7.0%)  0.03  0.01 
Age at Entry       
     5 to 9 years 4,416 (43.1%) 1,650 (36.4%)  0.14  0.03 
     10 to 14 years 3,447 (33.6%) 1,706 (37.7%)  0.08  0.01 
     15 to 19 years 2,387 (23.3%) 1,173 (25.9%)  0.06  0.03 
Physical Disability 43 (0.4%) 45 (1.0%)  0.06  0.01 
Parent       
     Substance abuse 2,893 (28.2%) 1,244 (27.5%)  0.02  0.01 
     Single parent 6,117 (59.7%) 2,694 (59.5)  0.00  0.01 
Placement       
     Foster care 3,668 (35.8%) 1,637 (36.1%)  0.01  0.01 
     Therapeutic foster care 353 (3.4%) 366 (8.1%)  0.17  0.03 
     Group care 1,054 (10.3%) 748 (16.5%)  0.17  0.04 
     Kinship care 3,388 (33.1%) 1,068 (23.6%)  0.22  0.05 
     Other 1,787 (17.4%) 710 (15.7%)  0.05  0.01 
Abuse History       
     Physical abuse 783 (7.6) 377 (8.3%)  0.02  0.00 
     Sexual abuse 595 (5.8%) 277 (6.1%)  0.01  0.00 
     Neglect 7,838 (76.5%) 3,320 (73.3%)  0.07  0.02 
     Other 2,111 (20.6%) 1,063 (23.5%)  0.07  0.02 
Diagnosis 1774 (17.3%) 2,418 (53.4%)  0.72*  0.04 
     Disruptive disorder 683 (6.7%) 1,100 (24.3%)  0.41*  0.08 
     ADHD 240 (2.3%) 790 (17.4%)  0.40*  0.20 
     Depressive disorders 138 (1.3%) 174 (3.8%)  0.13  0.00 
     Anxiety disorders 137 (1.3%) 100 (2.2%)  0.06  0.08 
     Adjustment disorder 305 (3.0%) 113 (2.5%)  0.03  0.28* 
     Other mental disorders 8,476 (82.7%) 141 (3.1%)  0.03  0.20 
Entry cohort (median) 2008 2008  0.05  0.04 
Rurality       
     Urban (ref. Rural) 7,373 (71.9%) 3,335 (73.6%)  0.04  0.01 
*Standardized effect sizes in absolute values greater than 0.25 
a 69.4% of total sample  
b 30.6% of total sample 
Note. ADHD = Attention deficit and hyperactivity disorder.  
The weighted sample was constructed on the standardized inverse-probability of the treatment weighted 
(IPTW) 
 
Descriptive Data: Outcomes 
Length of time in care. The median length of time was calculated using the Kaplan 
Meier survival analysis. In the unweighted sample, the median length of time in care for a non-
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medicated child was 9.7 months (SD = 0.12) whereas children who were medicated had a 
median time in care of 8.6 months (SD = 0.17; see Table 14). This difference was statistically 
significant according to Peto’s log-rank test (X2 = 418.04, p < .0001). 
Table 14. Description of outcome variables in raw dataset 
Outcome 
Medicated 
(n=4,529) 
Non-Medicated 
(n=10,250) 
Length of Time in Care   
     Mean (SE; in months) 8.6 (0.17) 9.7 (0.12) 
Placement Stability   
    Average number of placements (SD) 4.8 (5.2) 2.8 (3.6) 
Exit Type   
     Reunification 1,650 (36.4%) 4,178 (40.8%) 
     Adoption 692 (15.3%) 1,344 (13.1%) 
     Guardianship 1,126 (24.9%) 3,072 (30.0%) 
     No Permanency 1,061 (23.4%) 1,656 (16.2%) 
 
Placement disruptions. In the unadjusted dataset, children who were medicated had a 
mean number of 4.8 placement changes vs. 2.8 placement changes for the non-medicated group. 
Exit type. The two samples were similar in exit type based on the unweighted sample 
with reunification as the most common exit type experienced by over a third of the sample. The 
least common experience was no permanency experienced by about 12% of the population.  
Results of Outcome Analysis 
Length of time in care. The survival curves show that non-medicated children were 
more likely to exit foster care than the medicated children until about 20 months at which point 
the medicated children exited more slowly than the non-medicated children (see Figure 9). The 
Kernel-smoothed hazard functions graph also shows that medicated children had higher hazards 
of exiting foster care than their non-medicated counterparts in the first few months after entering 
care. Inferences from higher values of months should be made with caution as smaller samples at 
the higher months may contribute to results that are unstable (see Figure 10). 
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Figure 9. Survival curves of exit to permanency by psychotropic medication treatment 
 
 
Figure 10. Kernel-smoothed hazard functions of exit to permanency  
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Table 15 shows the results of the Cox regression models for the number of months in 
care. The table provides information on the overall model chi-square, as well as hazard ratio and 
95% confidence interval for hazard ratio. According to the model fit statistics -2 Log-Likelihood, 
Akaike Information Criteria (AIC), and the Schwarz criteria (SBC) tests, adding the variables to 
the Cox regression model improved the model fit. The likelihood ratio test also confirms that at 
least one of the regression coefficients was significantly different from 0 (X2= 17,294.05 (26), p 
<.0001).  
The hazard ratio corresponds to the percentage change in the hazard rate for a particular 
value of the variable relative to the comparison category for that variable while controlling for all 
other variables. In the weighted model, medicated children were slower to exit care into 
permanency than children without medication: they had about a 60% (HR = 0.40) decrease in the 
hazard rate compared to non-medicated children. This decrease in rate to permanency was 
statistically significant (p < .0001). 
Children of other races were slower to exit than White children by about 13% (HR = 
1.13). Children with parents with substance abuse issues did not have an effect on hazard of 
exiting care. Children from single parents exited care more slowly but only by about 5% (HR = 
1.05). Children in foster care (HR = 1.95), therapeutic foster care (HR = 1.82), and group homes  
(HR = 1.45) exited care faster than children in “other” placements. Only kinship care did not 
have a significant association with time to exit. Interpreting the results for abuse is difficult 
because children may have more than one abuse type and records for abuse can change during 
the child’s spell. Later cohorts exited care faster (HR = 2.03) but children with more placement 
changes stayed in care longer (HR = 0.51). 
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Table 15. Effect sizes from Cox regression model for time to permanency 
Variable Hazard Ratio (95% CI) p value 
Medication  0.40 (0.37-0.41) < .0001 
   
Gender   
    Male (ref. Female) 0.99 (0.96-1.04) NS 
Average age 1.01 (1.01-1.02) < .001 
Race   
    Black (ref. White) 1.11 (1.06-1.16) < .0001 
    Hispanic (ref. White) 0.99 (0.92-1.07) NS 
    Other (ref. White) 1.13 (1.04-1.22) < .01 
MH diagnosis   
     Disruptive disorder 0.93 (0.87-0.98) <.05 
     ADHD 0.94 (0.88-1.00) NS 
     Depressive disorders 1.00 (0.90-1.10) NS 
     Anxiety disorders 0.93 (0.83-1.03) NS 
     Adjustment disorder 1.03 (0.94-1.14) NS 
     Other mental disorders 0.88 (0.78-0.98) <.05 
Physical disability 1.01 (0.77-1.31) NS 
Placement   
    Foster care 1.95 (1.82-2.08) < .0001 
    Therapeutic foster care 1.82 (1.69-1.96) < .0001 
    Kinship care 0.97 (0.90-1.04) NS 
    Group home 1.45 (1.34-1.57) < .0001 
    Other - - 
Abuse   
    Physical 1.11 (1.04-1.19) < .01 
    Sex 1.20 (1.10-1.30) < .0001 
    Neglect 1.08 (0.96-1.22) NS 
    Other 1.09 (0.96-1.23) NS 
Parental characteristics   
    Substance abuse 0.98 (0.94-1.03) NS 
    Single parent 1.05 (1.01-1.09) <.05 
Entry cohort 2.03 (2.00-2.06) < .0001 
Metropolitan 0.99 (0.95-1.04) NS 
Number of placement changes 0.51 (0.50-0.52) < .0001 
Event and censored values:   
    Events: 12,049   
    Censored: 40,083   
    Total: 52,132   
    % Censored: 76.89   
   
 Without 
covariates 
With covariates Model chi-square df p 
-2 log L 167,004.03 149,710.00 17,294.05 26 <.0001 
Note. ADHD = Attention-deficit hyperactivity disorder; CI = Confidence interval; NS = Non-
significant; ref. = Reference. 
 
Most mental health diagnoses were not associated with length of stay although those 
diagnosed with other mental disorders were slower to exit to permanency (HR = 0.88). Although 
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disruptive disorder also had a statistically significant HR less than one, the HR was so close to 
one that this difference may not provide clinically valuable information.  
Number of placements.  
 
The degree-of-freedom chi-square test indicated that medication use was a statistically 
significant predictor of number of placement changes: Medicated children had fewer placement 
changes than their non-medicated counterparts: for a medicated child, the rate ratio for placement 
change was expected to decrease by a factor of 0.83, while holding all other variables in the 
model constant. In other words, medication use reduced the incidence rate of placement change 
by 17%. Hispanic children were also more stable compared to their White counterpart (IRR = 
0.90).  
Foster children with a mental health diagnosis were also less stable than children without 
a mental health diagnosis (IRR = 1.25). Children in foster care, therapeutic foster care or group 
home were more likely to experience a placement change throughout their time in care. Kinship 
care was the only out of home placement that did not have a significant association with the 
incidence of a placement change. All other characteristics were either not statistically significant 
or had IRRs too close to 1.0 to make any meaningful statements (see Table 16). 
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Table 16. Factors associated with incidence of placement change 
   Wald 95% CI   
Characteristic B Std. 
Error 
Lower Higher  Incidence Rate 
Ratio 
Medication  -0.19*** 0.02 -0.23 -0.15  0.83 
       
Male       
    Male (ref. Female) 0.02 0.02 -0.02 0.06  1.02 
Age of Entry 0.03*** 0.00 0.02 0.03  1.03 
Race       
    Black (ref. White) -0.03 0.02 -0.07 0.02  0.97 
    Hispanic (ref. White) -0.10** 0.04 -0.17 -0.03  0.90 
    Other (ref. White) 0.01 0.04 -0.06 0.09  1.01 
MH diagnosis 0.22*** 0.02 0.18 0.26  1.25 
Physical disability -0.04 0.11 -0.26 0.18  0.96 
Placement       
    Foster care 0.14*** 0.02 0.10 0.19  1.15 
    Therapeutic FC 0.29*** 0.03 0.24 0.35  1.34 
    Kinship care 0.01 0.02 -0.04 0.05  1.01 
    Group home 0.27*** 0.03 0.22 0.32  1.31 
    Other       
Abuse       
    Physical 0.02 0.04 -0.05 0.09  1.02 
    Sex -0.02 0.04 -0.10 0.06  0.98 
    Neglect 0.01 0.06 -0.11 0.12  1.01 
    Other 0.05 0.06 -0.07 0.17  1.05 
Parents       
    Substance abuse -0.07*** 0.02 -0.12 -0.03  0.93 
    Single parent 0.02 0.02 -0.02 0.06  1.02 
Entry Cohort 0.06*** 0.01 0.05 0.07  1.06 
Metro -0.01 0.02 -0.06 0.03  0.99 
Note.  FC = Foster care; MH = Mental health; ref. = Reference.  
* p ≤ .05; ** p  ≤ .01.; *** p  ≤ .001 
Exit type. The likelihood ratio chi-square test of 19,234.23 with a p-value of <.0001 
indicated that the model as a whole fit better than an empty model. According to the Wald chi-
square test, overall exit type differed significantly by medication (X2 = 135.2, df = 3, p < .0001). 
Medication use had a statistically significant negative effect on a child’s likelihood of 
exiting care by reunification (OR = 0.50) and guardianship (OR = 0.59). Medication use did not 
have a statistically significant effect on adoption. Children with disruptive disorders were also 
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less likely to exit care with any of the three permanent exit types. Only depressive disorder had a 
significantly significant positive likelihood of exiting care through adoption (OR = 1.70). 
Table 17. Multinomial logit for exit type of children in foster care 
Characteristic 
Reunification v. No 
permanency  
Guardianship v.  
No permanency  
Adoption v. No 
permanency 
OR (95% CI)   OR (95% CI)   OR (95% CI)  
Medication  0.50 (0.43-0.58) ***  0.59 (0.50-0.70) ***  1.03 (0.85-1.25)  
         
Male          
    Male (ref. Female) 1.06 (0.88-1.28)   1.08 (0.88-1.32)   0.85 (0.66-1.09)  
Age of entry 0.74 (0.72-0.76) ***  0.73 (0.71-0.76) ***  0.58 (0.56-0.61) *** 
Race         
    Black (ref. White) 0.65 (0.53-0.79) ***  0.75 (0.60-0.93) *  0.72 (0.55-0.94) * 
    Hispanic (ref. White) 0.62 (0.43-0.88) **  0.75 (0.49-1.14)   0.75 (0.49-1.15)  
    Other (ref. White) 0.84 (0.57-1.24)   0.92 (0.59-1.41)   1.02 (0.62-1.68)  
MH diagnosis          
     Disruptive disorder 0.78 (0.68-0.90) ***  0.69 (0.59-0.81) ***  0.74 (0.60-0.91) ** 
     ADHD 0.88 (0.70-1.10)   0.97 (0.77-1.22)   1.17 (0.90-1.53)  
     Depressive disorder 0.84 (0.65-1.08)   0.96 (0.73-1.28)   1.08 (0.69-1.70)  
     Anxiety 1.07 (0.79-1.43)   0.81 (0.58-1.13)   1.70 (1.23-2.34) ** 
     Adjustment 0.87 (0.71-1.07)   0.97 (0.78-1.20)   1.13 (0.89-1.45)  
     Other 1.05 (0.81-1.35)   1.07 (0.81-1.42)   1.09 (0.77-1.55)  
Physical disability 0.36 (0.15-0.83) *  0.30 (0.12-0.77) *  0.27 (0.08-0.87) * 
Placement         
    Foster care (ref. Other) 0.42 (0.36-0.50) ***  0.57 (0.47-0.69) ***  2.03 (1.55-2.64) *** 
    Therapeutic FC (ref. Other) 0.26 (0.21-0.32) ***  0.38 (0.29-0.50) ***  1.70 (1.23-2.34) ** 
    Kinship care (ref. Other) 0.64 (0.53-0.78) ***  2.39 (1.94-2.94) ***  3.56 (2.65-4.78) *** 
    Group home (ref. Other) 0.57 (0.49-0.66) ***  0.67 (0.55-0.81) ***  1.57 (1.14-2.18) ** 
Abuse         
    Physical 1.07 (0.77-1.50)   0.95 (0.65-1.39)   1.05 (0.69-1.62)  
    Sex 0.74 (0.52-1.05)   0.69 (0.47-1.00)   0.78 (0.49-1.23)  
    Neglect 0.87 (0.54-1.39)   0.64 (0.39-1.06)   1.34 (0.65-2.76)  
    Other 0.77 (0.46-1.27)   0.51 (0.30-0.88) *  0.81 (0.37-1.77)  
Parents         
    Substance abuse 0.89 (0.71-1.12)   1.20 (0.94-1.53)   1.18 (0.89-1.56)  
    Single parent 0.81 (0.67-0.97) *  1.08 (0.88-1.33)   0.93 (0.73-1.19)  
Entry Cohort 1.07 (1.02-1.12) *  1.06 (1.01-1.12) *  1.09 (1.02-1.16) * 
Number of months in care 0.95 (0.94-0.96) ***  0.96 (0.95-0.97) ***  1.05 (1.04-1.06) *** 
Metropolitan (ref. Rural) 0.89 (0.72-1.09)   0.72 (0.57-0.91) **  1.22 (0.91-1.62)  
Placement changes 0.94 (0.90-0.97) **  0.96 (0.92-1.00) *  0.71 (0.66-0.76) *** 
Note. ADHD = Attention-deficit hyperactivity disorder; FC = Foster care; MH = Mental health; ref. = Reference. 
* p ≤ .05; ** p ≤ .01; *** p ≤ .001 
 
 Age of entry had a negative effect on exiting to permanency: children who entered care 
later in life were less likely to exit by reunification, guardianship, or adoption. Black children 
were also less likely to exit to permanency. Parental substance abuse was not significant in exit 
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type but having a single parent decreased the likelihood of reunification (OR = 0.81). Living in a 
metropolitan county decreased the likelihood of exiting by guardianship (OR = 0.72). 
Children in foster care, therapeutic foster care, and group homes were more likely to exit 
by adoption and less likely to exit by reunification or guardianship. Only children living in 
kinship care had a higher probability of exiting through guardianship (OR = 2.39). History of 
abuse was not predictive of exit type except for “other” abuse which had a lower odds ratio of 
leaving care through guardianship. Having more placement changes decreased the chances of 
exiting to permanency, particularly by adoption (OR = 0.71). Later cohorts were slightly more 
likely to exit through a permanent exit type but the longer a child, they were slightly less likely 
to reunify or exit through guardianship but slightly more likely to exit through adoption (see 
Table 17). 
Sensitivity Analysis 
 The analyses were conducted without IPTW weights and there were significant changes 
in the results for all three analyses conducted. Several of the variables differed in statistical 
significance, effect sizes, and even direction. This demonstrates the need for an IPTW statistical 
control. 
Discussion 
Although there has been nearly a decade of research in the area of psychotropic 
medication use among children in foster care, much of this research has remained limited to 
epidemiological studies. Studies have yet to examine the outcomes of medicating children in 
foster care. One of the major challenges in studying the outcomes of psychotropic medication 
use with children in foster care is addressing confounding variables such as adverse history and 
higher rates of mental illness.  
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The use of statistical advancements such as the inverse-probability of treatment weights 
to address confoundedness was a viable solution to using administrative data to investigate 
effects of medication use on foster care outcomes. There were differences in several baseline 
characteristics of children who were medicated vs. those who were not medicated that were 
potential confounders to the effects of medication use on outcomes. Nearly all these differences 
were statistically balanced after using IPTW except for children diagnosed with adjustment 
disorders. Furthermore, these weights allowed for time-varying information to be used in 
analysis.  
Despite the advantages of using advanced statistical techniques with linked 
administrative data, many states face technical barriers to cross-system data sharing such as the 
availability of information specific to foster care populations, data matching across systems, 
different types of data collected, and data propriety (GAO, 2017). Data matching and cleaning is 
a difficult and time-consuming process and states face limitations in time and resources for data 
gathering, given other competing priorities. Privacy is also an issue as agencies are reluctant to 
share sensitive data due to privacy protections under the Health Insurance Portability and 
Accountability Act (1996) for health information and Family Educational Rights and Privacy Act 
(1974) for education information. Some state child welfare and Medicaid officials were able to 
share data and overcome privacy concerns through negotiating written agreements and educating 
stakeholders how to legally share data (GAO, 2017). Other solutions involve hiring a contractor 
to provide matched data without providing personal data or granting certain officials access to 
personal information who then assign anonymous identifiers to each child to protect privacy 
while facilitating data sharing. 
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Children who were medicated with psychotropic medication were in care for longer than 
children who were not medicated. The findings from this study dismiss the narrative that 
medication use is a quick-fix for foster children. Perhaps the reliance on medication may prolong 
the time the child is in care because it takes time to appropriately adjust medication. Or there 
may be other factors that the medicated children may be experiencing that unmedicated children 
do not experience that may be prolonging the time to permanency. For example, if part of the 
court-ordered permanency planning includes establishing mental health care, delays in finding 
and meeting an appropriate specialist may contribute to extended times in foster care. Studies 
have found that long wait times to receive mental health services is a concern expressed by many 
practitioners (O’Brien, Harvey, Howse, Reardon, &Creswell, 2016; Pfefferle, 2007). Future 
studies are needed that examines possible contributors of increasing time in foster care with 
psychotropic medication. 
Children who were medicated had better placement stability. Although their incidence 
rate of placement disruption was lower, their mean number of placement changes was higher 
than the non-medicated group. This disparity may be because medicated children tend to be in 
care longer and so when accounting for the exposure of time, the rate of disruption at any 
moment may be lower. Since problem behavior can be an indicator of risk for placement 
disruptions, psychotropic medications that help treat problem behavior, in theory, may help 
promote placement stability. A randomized control study of a family-based intervention for 
preschoolers in treatment foster care found that addressing disruptive behavior increased 
placement stability (Fisher, Stoolmiller, Mannering, Takahashi, & Chamberlain, 2011). The 
positive effect of medication use on placement stability may be an indication that decreasing 
disruptive behavior through medication also promotes placement stability. It is important to 
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minimize placement disruptions when at all possible because of its association with increased 
mental health needs and poor social emotional outcomes (James et al., 2004; Lewis, Dozier, 
Ackerman, & Sepulveda-Kozakowski, 2007; Rubin et al., 2004; Ryan & Testa, 2005). Future 
studies on placement stability may be improved with the use of more precise and validated 
measurements of disruptive behavior such as the Child and Adolescent Disruptive Behavior 
Inventory (CADBI; Burns, Boe, Walsh, Sommers-Flanagan, & Teegarden, 2001). Studies 
comparing evidence-based psychosocial interventions with or without psychotropic medication 
are needed to further examine strategies to minimize disruptive behavior and increase placement 
stability. 
Medicated children were less likely to achieve permanency. Children who were mediated 
were less likely to be reunified or exit through guardianship and there was no statistically 
significant effect on adoption. This finding indicates that medication is insufficient or is 
unrelated to achieving permanency. Medicating children addresses the symptoms of the child’s 
mental illness but does not provide parents with the skills necessary to manage their child’s 
behavior and/or emotions. Perhaps children who are medicated are less likely to be reunified 
with their parents because necessary changes cannot be made at home to create a safe 
environment for the children to return to when resources are focused solely on the child. More 
studies are needed to see what other services are provided to support the family concurrently 
with medication treatments. Meeting the needs of parents may be a greater challenge than simply 
medicating children because parents are overwhelmingly poor and struggle to meet the most 
basic needs for food, clothing, housing and transportation (Marcenko, Newby, Lee, Courtney, & 
Brennan, 2009) and accessing services, even if available, compete with the time and energy 
127 
necessary to meet other concreate needs essential to providing a safe and stable home that their 
child can return to.  
Limitations and Strengths 
One limitation of this study is the reliance on administrative data as the primary data 
source. Despite its advantages such as large sample sizes and reduced potential for social 
desirability bias, administrative data are limited in scope as they are designed to accommodate 
the needs of administrators, not researchers (Drake & Johnson-Reid, 1999; English, Branford, & 
Coghlen 2000; Vogel, 1999). Administrative data are often categorical and dichotomous in 
nature rather than more detailed indicators of the phenomenon of interest. In addition, there is 
risk that the data are inaccurate or incomplete.  
Despite large sample sizes from administrative data sources, excluding children with 
extraordinary circumstances such as those diagnosed with the most severe psychotic disorders or 
children under the age of five resulted in a considerable smaller final sample. As a result, some 
characteristics were not well represented in both sample groups. Having large samples such as 
from multiple states or for longer study window would result in a larger sample size. 
Intervention fidelity is also a limitation of the study. A Medicaid bill for a psychotropic 
medication is used as a proxy for medication use; however, whether the child took the 
medication or not is unknown. A literature review on stimulant compliance with pediatric 
psychopharmacology found that reported levels of compliance ranged from 56% to 75% (Hack 
& Chow, 2004). If medication compliance and adherence is low, then the treatment effect of 
psychotropic medication found in this study may be underestimated. 
In this study, careful examination and data processing were performed to ensure that the 
data were as complete as possible while the range of data elements important to this research 
128 
area was still represented. The richness of data that administrative data affords allows the 
researcher to follow large numbers of children entering care over time and track their movement 
while in care; such data are often cost-prohibitive to collect through primary data collection. 
Furthermore, because of the sensitive nature of researching the medication of children, and 
especially a particularly vulnerable population such as those in the child welfare system, 
secondary data analysis is a humane, safe, and non-intrusive means of better understanding the 
practice of medicating children in foster care with psychotropic medication. These advantages 
contribute to the rise in popularity of utilizing administrative data in child welfare research.  
Propensity scores cannot account for unobserved confounders and, if present, residual 
bias would remain. Although variables to balance covariates were carefully considered using 
prior research and empirical evidence, there may be other factors that have not been accounted 
for. Other possible confounders may include the availability of child mental health specialists or 
the caretaker’s perception of medication use. In addition, although the propensity scores reduced 
the differences in the two samples dramatically, there was still one variable (adjustment disorder) 
that were statistically different between the two groups. Interpretations of the causal analyses 
should be made with the caveat that adjustment disorder may be a confounding factor.  
Foster care studies are highly complex in nature due to many complicated social and 
clinical factors that change with time. For example, a child in foster care may experience several 
types of placements during their time in care. While time-varying covariates were accounted for 
with advanced statistical procedures, interpretation of results may be a challenge due to the 
nature of foster care experiences. Changing mental health diagnoses were addressed by applying 
a hierarchical categorization that helps reduce interpretational challenges due to co-morbidities. 
Finally, this study used a single state’s data and thereby, may not be generalizable to other states.  
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Conclusion 
In this paper, IPTW was used to provide a causal framework for analyzing the effect of 
psychotropic medication use on permanency outcomes. By employing this method, 
administrative data were able to be analyzed in a way that approximates the gold standard of 
study design, the randomized control trial. This approach allowed for greater insight on the 
effects of medication use on foster care experiences and permanency outcomes. For example, it 
appears that foster children stay in care longer and are less likely to exit to permanency. 
However, medication use appears to increase placement stability.  
To knowledge, this is the first paper to use statistical techniques on administrative data to 
make causal inferences of the effects of medication use on foster care experiences and 
permanency outcomes. IPTW is a promising and viable technique that allows researchers to use 
readily available administrative data. These administrative data have sample sizes and study 
periods that are far greater and longer than any other primary data collection source. In this age 
of big data, greater consideration of statistical techniques that can be applied to administrative 
data is warranted. 
This paper is also novel in that it is among the first studies to examine proximal foster 
care outcomes of length of stay, placement stability, and exits to permanency with the use of 
psychotropic medication among foster youth. This study found that foster children who were 
medicated stayed experienced more stable placements. However, these children also stayed in 
care longer and were less likely to exit to permanency than their non-medicated counterparts. 
Additional resources are needed to help improve these child welfare outcomes as medication, in 
itself, does not improve these measures. Studying additional measures such as health, education, 
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and juvenile justice outcome measures may also help determine whether the care and services 
provided help children in foster care lead healthy and productive lives.  
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APPENDIX C: PSYCHOTROPIC DRUG CLASSES AND COMMON USES 
Drug class Drug Name (Trade Name) 
Types of conditions 
treated by drug class 
Examples of possible 
adverse side effects 
Stimulants Atomoxetine (Strattera) 
Lisdexamfetamine dimesylate 
(Vyvanse) 
Methylphenidate (Ritalin, Concerta) 
Amphetamine (Adderall) 
Dextroamphetamine (Dexedrine, 
Dextrostat) 
ADD/ADHD Decreased appetite 
Tics 
Psychosis 
Flat affect 
Difficulty sleeping 
Anxiolytic 
(Antianxiety) 
Clonazepam (Klonopin) 
Lorazepam (Ativan) 
Alprazolam (Xanax) 
Generalized anxiety 
disorder 
Post-traumatic stress 
disorder 
Social phobias 
Dependence 
Drowsiness and dizziness 
Blurred vision 
Nightmares 
Headaches 
Antidepressants Fluoxetine (Prozac) 
Citalopram (Celexa) 
Sertraline (Zoloft) 
Paroxetine (Paxil) 
Escitalopram (Lexapro) 
Venlafaxine (Effexor) 
Duloxetine (Cymbalta) 
Bupropion (Wellbutrin) 
Depression 
Generalized anxiety 
disorder 
Obsessive-compulsive 
disorder 
Social phobia 
Suicidal thoughts 
Sleeplessness or drowsiness 
Agitation 
Sexual dysfunction 
Weight gain 
Nausea and vomiting 
Antipsychotics Conventional 
Chlorpromazine (Thorazine) 
Haloperidol (Haldol) 
 
Atypical 
Risperidone (Risperdal) 
Olanzapine (Zyprexa) 
Quietiapine (Seroquel) 
Ziprasidone (Geodon) 
Aripiprazole (Abilify) 
Bipolar disorder 
Schizophrenia 
Tourette’s syndrome 
Rigidity (muscular tension) 
Tremor 
Tardive dyskinesia 
(uncontrollable movements) 
Diabetes 
High cholesterol 
Weight gain 
Neuroleptic malignant 
syndrome (a life-threatening 
neurological disorder) 
Mood stabilizers 
(Anti-manic 
agents) 
Lithium 
Divalproex sodium (Depakote) 
Carbamazepine (Tegretol) 
Lamotrigine (Lamcital) 
Oxcarbazepine (Trileptal) 
Bipolar disorder 
Depression 
Suicidal thoughts 
Loss of coordination 
Hallucinations 
Kidney, thyroid, liver, and 
pancreatic damage 
Polycystic ovarian 
syndrome 
Weight gain 
Alpha- 
adrenergic 
agonists (AAAs) 
Clonidine (Catapres) 
Guanfacine (Intuniv, Tenex) 
ADD/ADHD 
Insomnia and sleep 
problems 
PTSD 
Sedation 
Headache 
Excitability 
Restlessness 
(NIMH, 2016; GAO, 2011) 
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APPENDIX D: DIAGNOSTIC GROUP AND ICD-9 CODES 
Diagnostic group ICD-9-CM codes 
Schizophrenia; other psychoses  295, 297-298 
Pervasive developmental disorders; 
mental retardation 
299, 317-319 
Bipolar disorder  296.0, 296.1, 296.4-296.8, 301.13 
Disruptive disorders  312.0-312.4, 312.81, 312.82, 312.89, 312.9, 313.81 
Depressive disorders  293.83, 296.2, 296.3, 296.9, 298.0, 300.4, 311 
Anxiety disorders  293.84, 300.0, 300.2, 300.3, 308.3, 309.21, 309.81, 
313.0, 313.2, 313.89 
Adjustment disorder  308.0-308.2, 308.4, 308.9, 309.0-309.4, 309.82, 309.83, 
309.89, 309.9 
Communication or learning 
disorders  
307.0, 307.9, 315.0-315.2, 315.31, 315.32, 315.39, 
315.9 
Other mental disorders  290-319 (includes only the codes not listed above) 
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SUMMARY 
 
 There are several important findings in this dissertation. First, a substantial proportion of 
children in foster care are treated with psychotropic medication. This finding was consistent in 
the systematic literature review and meta-analysis as well as in an additional large-scale primary 
data-source. Financial incentives by way of reimbursement policies that favor brief medication 
management visits rather than psychotherapy may be contributing to the prevalence of 
medication use among children in foster care as well as a decline in the number of psychiatrists 
specializing in psychotherapy (Motjabai & Olfsen, 2008).   
Although there was variability in quality and methodology of studies that have been 
conducted, there were some consistent findings that provide insight on which children in our 
child welfare system are more likely to receive psychotropic medication. For example, males, 
Whites, older children, physical abuse, and children living in out-of-home placements were 
consistently more likely to receive psychotropic medication. Unlike prior studies, this study 
found a significant decrease in psychotropic medication use for children living in rural areas. 
Also, the medication prevalence rate and correlations with child characteristics from this one-
state study was consistent with the findings of other studies which shows that they are replicable 
and confidently generalized. This study found that stimulants, antidepressants, and 
antipsychotics were the most popular psychotropic medication prescribed. Conducting a study of 
the entire foster care population revealed possible subpopulations that have vastly different 
medication patterns such as those with severe psychotic disorders (i.e., schizophrenia, pervasive 
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developmental disorder/mental retardation, and bipolar disorder) as well as children under the 
age of 5.  
 Understanding the variables that predict the use of psychotropic medication use among 
children in foster care allowed for more advanced analysis to be applied with the large samples 
made available through existing administrative datasets. In particular, using the covariates that 
are believed to influence decisions on medication use (based on findings of the literature search 
of Paper I of this dissertation and the exploratory analysis on primary data of Paper II) helped 
construct propensity score weights in order to conduct causal analysis as demonstrated in Paper 
III. Furthermore, the richness of the administrative data allowed for even greater control of the 
time-varying covariates by using a particular form of propensity score weights known as the 
inverse probability of the treatment weights. One of the important contributions of this 
dissertation is that it demonstrates that advanced causal analysis using large-scale, administrative 
datasets is a viable form of research that is currently underutilized in the field (Palinkas, 2014). 
 Regarding the effect of psychotropic medication use on foster youth outcomes, this 
dissertation provides the first form of evidence that medicating children increases the time that 
the children stay in care and also decreases the chances of exiting through a permanent exit type. 
There was also some evidence that the use of medication increased the stability of foster children 
placements. The two samples differed statistically only on adjustment disorder but this diagnosis 
may be a possible source of confounding in the causal analysis.  
This dissertation is important for several reasons. As no previous systematic review of the 
use of psychotropic medication among children in foster care has been conducted, undertaking 
such an endeavor is timely to assess current understanding relating to the use of psychotropic 
medication in the child welfare population. Not only does this dissertation synthesize the body of 
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work relating to the use of psychotropic medication among children in foster care, but it also 
does the important work of appraising the body of literature that has been conducted thus far in 
this area. This effort revealed that virtually all the studies thus far were limited to descriptive and 
epidemiological analysis, which, while important in understanding the scope of the issue, is 
limited in its ability to provide practical guidance in the field. This dissertation identifies the 
need for the field to move beyond epidemiological studies. 
Additionally, this dissertation provides a significant contribution to the body of literature 
by rigorously examining the use of psychotropic medication by children in foster care with a 
large, state-wide sample that spans more than five years. Furthermore, the dissertation is a 
demonstration of how administrative data can be used to mimic randomized-control trials in 
order to conduct causal analysis. After conducting propensity score analysis with time-varying 
covariates, this study provides evidence of a causal relationship between medication use and 
length of time in care, placement stability, and permanency outcomes that may help child welfare 
social workers consider the effect of medication use during case planning.  
Overall Limitations  
 Despite the valuable contributions this dissertation makes, there are a few notable overall 
limitations. Despite specific criteria for inclusion of the systematic literature review, there was 
still variability in quality, methodology, and sample that made generalizing the knowledge more 
difficult. For example, some studies had samples from only certain residential treatment facilities 
or focused on specific sub-populations such as children with ADHD. The lack of consistency 
across studies on study populations and/or scope makes generalizing findings more challenging.  
 Another limitation is that the studies in Paper II and Paper II analyzed data from 
Medicaid claims records to identify children who were medicated. However, this measure is 
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different than measures of medication actually taken: not all medication from filled prescriptions 
is actually taken and estimates of nonadherence for psychotropic medication range from 20% to 
2%, with variations according to diagnosis (Coletti, Leigh, Gallelli, & Kafantaris, 2006; Julius, 
Novitsky, & Dubin, 2009). 
  There are also limitations that arise from the use of secondary, administrative data 
analysis. When using administrative datasets, the researcher lacks control over the variables in 
the dataset. These variables were constructed solely for administrative purposes and therefore, 
the researcher does not have control over what and how variables are constructed and collected 
(Harpe, 2009). For example, because behavioral data are not collected through the administrative 
process, behavioral problems can only be approximated using available proxy data such as 
clinical diagnosis. Also, when using administrative data, the researcher does not have control 
over the data collection process so data entry errors may result in incomplete or erroneous data. 
Therefore, careful and considerate data cleaning is required to ensure quality data. The necessary 
data cleaning procedure may result in deleted observations. However, the very large sample size 
afforded with the use of administrative data mitigates loss from deleted cases. 
 Finally, a major assumption of the propensity score analysis is that the variables used in 
constructing the propensity weights are inclusive of all characteristics that would predict 
medication use; this is also known as the assumption of “no unobserved confounders,” and the 
strong ignorability in treatment assignment (Rosenbaum & Rubin, 1983). Although variables 
were critically considered using knowledge established in the field, there is a risk that there is 
still some unobserved variable that may influence the use of psychotropic medication that was 
not measured or excluded which may not sufficiently account for possible selection bias such as 
caregiver beliefs on medication or the availability of child and adolescent mental health 
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specialists. Nevertheless, key covariates consistently linked to psychotropic medication use 
among foster children were included in this study and balanced through propensity score 
weighting. 
Directions for Future Research 
Despite support of causal effect, more research is needed to understand why medication 
has these particular effects on foster care outcomes. One hypothesis may be that the process of 
finding the appropriate medication to address the child’s emotional or behavioral issues is a long 
one—either because it takes a long time for the medications to biologically take effect, or 
because there are systemic issues, such as if a child must wait longer to see a specialist due to 
shortage of medical professionals. Supplementing this research with qualitative studies may help 
us understand the mechanism for why medicating children is leading to these outcomes. More 
importantly, child welfare caseworkers, administrators, and researchers may consider how 
medication use plays a role in improving permanency outcomes as well as how the time to exit 
may be safely expedited for children who receive medication. 
 Moreover, this dissertation revealed variability in the literature in how certain concepts 
were identified or classified which encumbers efforts to generalize findings across studies. 
Dissimilarities were found in age classifications, assessments of mental health, and even 
categorizations of relevant medication classes. A clear consensus or industry standard on foster 
care and psychotropic medication research would be beneficial in the future. 
 Finally, this dissertation takes advantage of large administrative datasets that exist in this 
age of big data. However, the experiences of foster care and mental health treatment are complex 
with many variabilities that overlap and change over time. The complex nature of foster care 
research, and social research in general, requires the use of advanced statistical controls to reduce 
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bias when using administrative data. Employing propensity scores and IPTW is one way to 
conduct causal research with administrative data as demonstrated in this dissertation. However, 
there are other methods that are used in other fields or are emerging which researchers should 
consider, such as marginal structural modeling used often in epidemiology to improve adjust for 
time-varying dependent exposures to treatment (Robins, Hernán, & Brumback, 2000). The 
opportunities to apply novel research methods when conducting research with administrative 
data continue to grow, making this a worthy endeavor in future research. 
Implications for Social Work 
 Medication may be one tool in addressing some of the behavioral needs of children in 
foster care which, in turn, may promote better foster care outcomes such as placement stability. 
However, children who are medicated had longer stays in care and were less likely to achieve 
permanency than children who were not medicated with psychotropic medication. Possible 
factors from the process of treating a child through medication that may contribute to longer 
lengths in foster care should be identified. One possible area to examine is whether there are 
barriers to connecting children with appropriate mental health specialists in a timely manner that 
may be delaying exits to permanency. Children that were medicated had more stable placements. 
Identifying and addressing disruptive behaviors, either by medication or other psychosocial 
interventions, may be an endeavor in promoting placement stabilities. Finally, the lower 
likelihood of children achieving permanency may be an indication that though children’s 
symptoms are being addressed through medication, there are other factors that are barriers to 
exiting to permanency. Additional resources are needed to improve permanency outcomes of the 
medicated foster care population. 
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